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CHECKLISTS AND ILLUSTRATIVE FINANCIAL STATEMENTS
FOR HEALTH CARE PROVIDERS
The checklists in this book have been developed by the staff of the 
Technical Information Division of the AICPA as a nonauthoritative 
practice aid. Readers should be aware of the following:
o The checklists and illustrative financial 
statements and reports have been updated to include 
FASB Statements through No. 105, AICPA Statements 
of Position through No. 90-7, and AICPA Statements 
on Auditing Standards through No. 64. The 
checklists and illustrative financial statements 
and reports should be modified, as appropriate, for 
subsequent pronouncements. In determining the 
applicability of a pronouncement, its effective 
date should be considered.
o The checklists and illustrative financial 
statements should be used by or under the 
supervision of persons having adequate technical 
training and proficiency in the application of 
generally accepted accounting principles, generally 
accepted auditing standards, and statements on 
standards for accounting and review services.
o The checklists do not represent minimum 
requirements and do not purport to be all 
inclusive. The referenced standards should be 
reviewed if clarification is desired as to whether 
the disclosure indicated is required or suggested, 
and to what extent the disclosure is relevant to 
the statements or report in question.
Users of the checklists and illustrative financial statements are urged 
to refer directly to the existing authoritative pronouncements when 
possible. If you have a question, please call the AICPA Technical 
Hotline (see back cover).
The authors wish to acknowledge the assistance of their colleagues, 
Robert E. Moran, CPA, and Michael A. Tursi, CPA, who served as 
consultants on this project.
John F. Hudson 
Vice President
Technical Standards and Services
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INTRODUCTION
General Comments on Providers of Health Care Services
Substantial changes have taken place since the AICPA first issued the 
Hospital Audit Guide in 1972. Health care costs have increased 
dramatically while the number of people requiring health care services 
has continued to rise. Concurrently, many governments and other third- 
party payors have adopted prospective payment systems which pay a 
predetermined fixed amount per case.
The Need for Guidance
Further, many health care providers are relying more heavily on debt 
financing to meet capital needs. As a result, various not-for-profit 
health care providers have converted to a profit-oriented status. Thus, 
a greater need for accountability to creditors and investors has 
emerged.
Relationship to Other Literature
FASB Concepts Statement No. 6, Elements of Financial Statements, 
provides a useful conceptual framework for those preparing financial 
statements to distinguish among financial statement elements for 
purposes of display of revenue, expenses, gains, and losses. Activities 
associated with the provision of health care services constitute the 
ongoing major or central operations of providers of health care 
services; therefore, revenues, expenses, gains, and losses arising from 
those activities are classified as "operating”. Gains and losses from 
transactions that are peripheral or incidental to the provision of 
health care services and from other events stemming from the environment 
that may be largely beyond the control of the entity and its management 
are classified as "nonoperating". Charity care is not included in 
revenues.
Marketable equity securities are reported at the lower of aggregate cost 
or market value in accordance with the requirements of FASB Statement 
No. 12, Accounting for Certain Marketable Securities. Investments 
accounted for on the equity method of accounting are reported in 
accordance with Accounting Principles Board Opinion No. 18, The Equity 
Method of Accounting for Investments in Common Stock.
Contingencies (such as those relating to pending appeals under rate­
setting systems and to state waivers under Medicare) are accounted for 
in accordance with FASB Statement No. 5, Accounting for Contingencies, 
as amended and interpreted.
Obligations incurred in advance refundings of debt, or for the purpose 
of early retirement or extinguishment of debt, are reported in 
accordance with FASB Statement No. 4, Reporting Gains and Losses From 
Extinguishment of Debt, as amended, and FASB Statement No. 76, 
Extinguishment of Debt.
1
Certain information of related entities should be disclosed in the notes 
to the financial statements if such entities are not consolidated or 
combined in accordance with ARB No. 51, Consolidated Financial 
Statements. as amended.
AICPA Statement of Position No. (SOP) 89-5, Financial Accounting and 
Reporting by Providers of Prepaid Health Care Services provides guidance 
on applying generally accepted accounting principles for health care 
costs, contract losses, stop-loss insurance, and contract acquisition 
costs of providers of prepaid health care services.
In July of 1990, the AICPA published a new audit and accounting guide 
entitled Audits of Providers of Health Care Services (the Guide). The 
Guide superseded the Hospital Audit Guide, and was prepared to assist 
the independent auditor in auditing and reporting on the financial 
statements of entities whose principal operations consist of providing 
health care services to individuals. Health care entities to which the 
Guide and these checklists apply include, but are not limited to, the 
following:
o Clinics, medical group practices, individual practitioners 
and practice associations, and other ambulatory care 
organizations
o Continuing care retirement communities (CCRCs)
o Health maintenance organizations and similar prepaid 
health care plans
o Home health agencies 
o Hospitals
o Nursing homes that provide skilled, intermediate, and less 
intensive levels of health care
A health care entity may be part of another organization, such as a 
government, a medical school or university, or a subsidiary of a 
corporation. The recommendations contained in the Guide and these 
checklists apply to the separate financial statements of health care 
entities that are either (a) investor-owned, (b) not-for-profit or
(c) state or local government-owned users of enterprise fund accounting 
and reporting. Therefore, when financial statements are prepared for a 
state or local governmental health care entity, the accounting, 
reporting, and disclosure requirements set forth in the Guide (and 
included in these checklists) and by pronouncements of the Governmental 
Accounting Standards Board apply.
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A liability should be reported by a CCRC recognizing the obligation to 
provide future services to, and use of facilities by, current residents 
without additional compensation for the terms of the contracts or the 
lives of the residents. [In November 1990, the AICPA issued SOP 90-8, 
Financial Accounting and Reporting by Continuing Care Retirement
Communities. The SOP is effective for years beginning after December 
14, 1990 and addresses revenue and cost recognition under continuing- 
care contracts. Due to current publishing schedule constraints, this 
SOP will be addressed in a future revision of these checklists].
Basic Financial Statements
The basic financial statements of not-for-profit and governmental health 
care entities generally consist of a balance sheet, a statement of 
revenue and expenses of general funds, a statement of changes in fund 
balances, and a statement of cash flows of general funds [and restricted 
funds of governmental entities]. The basic financial statements of 
investor-owned health care entities are similar to those of other 
investor-owned entities.
Aggregated (combined fund) and disaggregated (layered fund) balance 
sheets are acceptable alternatives to reporting financial position of 
not-for-profit health care entities and governmental hospitals.
General Comments on the Use of Checklists
Although authoritative literature does not require the use of a 
checklist, many auditors and accountants find it helpful to use as a 
practice aid in the preparation of financial statements and reports. 
The format and content of a checklist often varies. Some firms have 
developed their own checklists for internal use, and may have also 
developed specialized checklists to meet the needs of their practices 
(such as checklists for clients in particular industries or clients that 
report to the SEC). Some state CPA societies have developed checklists 
as practice aids which may be available to other practitioners as well 
as to their own members. Various commercial publishers include 
checklists in certain of their publications.
A checklist typically consists of a number of concise questions that are 
accompanied by references to the appropriate, existing authoritative 
literature. The extent of detail included in a checklist varies with 
the judgment of its authors regarding to what extent to refer to and to 
elaborate on the reference, without developing a checklist that is too 
long and unwieldy. Accordingly, a checklist may serve as a convenient 
memory aid, but it cannot be used as a substitute for direct reference 
to the existing authoritative literature.
A checklist usually makes a provision for checking off or initialling 
each question to indicate that it has been answered. The format used in 
these checklists provides for a "Yes," "No," and "N/A" (not applicable) 
response. [Remarks may be written in the margins or on a separate, 
cross-referenced memorandum.]
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Design of These Checklists
The financial statement checklist is designed to assist accountants in 
the preparation and presentation of financial statements of providers of 
health care services. The report checklists are intended to assist the 
independent auditor or accountant in reporting on such statements.
Caveats
The use of a checklist requires the exercise of individual professional 
judgment. A checklist is not intended to be all-inclusive, nor to 
present minimum requirements, and may require modification based on the 
circumstances of a particular engagement.
Users need to modify a checklist for any pronouncements issued 
subsequent to those from which the checklist is derived.
These checklists have been developed by the staff of the Technical 
Information Division of the AICPA as nonauthoritative practice aids.
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EXPLANATION OF REFERENCES
AAG-HEA or Guide = AICPA Audits of Providers of Health Care Services
APB = Accounting Principles Board Opinion
AR = Section in AICPA Professional Standards (vol. 2)
ARB = Accounting Research Bulletin
AU = Section in AICPA Professional Standards (vol. 1)
CT = FASB Accounting Standards Current Text
FASBI = Financial Accounting Standards Board Interpretation
SAS = Statement on Auditing Standards
SFAS = Financial Accounting Standards Board Statement
SOP = AICPA Statement of Position
SSARS = Statement on Standards for Accounting and
Review Services
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CHECKLIST QUESTIONNAIRE
This checklist has been developed by the staff of the Technical 
Information Division of the AICPA as a nonauthoritative practice 
aid.
Yes No
I. ACCOUNTING PRINCIPLES OF MEASUREMENT AND
DISCLOSURE
A. Application of Generally Accepted Accounting 
Principles
1. Are the financial statements prepared in 
conformity with generally accepted
accounting principles (GAAP)? _____ ___
2. Have health care entities operated by state 
or local governments considered statements 
and interpretations of the Governmental 
Accounting Standards Board (GASB)?
[AAG-HEA, sec. 3.1] _________
B. Fund Accounting
1. General funds
a. Are general funds of not-for-profit 
entities used to account for resources not 
restricted by donors?
b. Are assets and liabilities classified as 
current or noncurrent in conformity with 
GAAP?
[AAG-HEA, sec. 3.4]
c. Are the following assets whose use is 
limited included in the general funds?
(1).  Board-designated assets?
(2).  Proceeds of debt issues and funds
deposited with a trustee (limited to use 
in accordance with requirements of an 
indenture)?
(3).  Other assets whose use is limited
through an agreement between the entity
7
N/A
Yes No N/A
and an outside party other than a donor 
(such as assets set aside under 
self-insurance funding arrangements)? 
[AAG-HEA, sec. 3.5]
(4).  Agency funds?
d. Are transactions involving receipt and 
disbursement of agency funds excluded from 
the results of operations?
[AAG-HEA, sec. 3.6]
e. Is property and equipment used for general 
operations (and the related liabilities) 
reported in the general funds?
f. Is property not used for general 
operations (such as that acquired for 
future expansion or investment purposes) 
presented separately in the general funds? 
[AAG-HEA, sec. 3.7]
2. Donor-restricted funds
a. Is each restricted resource accounted for 
in accordance with the instructions of the 
donor or grantor?
[AAG-HEA, sec. 3.8]
b. Are specific-purpose funds recorded as 
additions to the restricted fund balance 
when received?
c. Are specific purpose funds reclassified as 
revenue of general funds when expenditures 
are incurred for the intended purpose? 
[AAG-HEA, sec. 3.9]
d. Are donor-restricted resources for 
additions to property and equipment 
reported in restricted plant replacement 
and expansion funds?
e. Was a reclassification of resources from 
the plant replacement and expansion fund 
balance to the general fund balance 
reported in the statement of changes in 
fund balances when expenditures are
8
Yes
incurred for the purpose intended by the 
donor?
[AAG-HEA, sec. 3.10]
f. Do the term endowment funds include 
resources the principal of which may be 
expended after the donor-imposed time or 
other restrictions are satisfied?
g. Is all pertinent information about the 
term endowment funds disclosed in the 
notes?
h. Are the term endowment funds that became 
available for unrestricted purposes 
reported as revenue in the statement of 
revenue and expenses?
i. Are the term endowment funds that became 
available but are further restricted under 
the provisions of the term endowment shown 
as a reclassification to the appropriate 
donor-restricted fund in the statement of 
changes in fund balances?
[AAG-HEA, sec. 3.11]
j. Do the endowment funds include resources 
whose principal may not be expended?
k. Is the investment income used in 
accordance with the donors’ stipulations, 
if any?
[AAG-HEA, sec. 3.13]
C. Donated Funds Held in Trust
1. Are resources that are held in a trust (by 
anyone independent of the entity), of which 
the entity is not the remainderman, excluded 
from the balance sheet?
2. Is the existence of resources described 
above disclosed?
[AAG-HEA, sec. 3.14]
3. Are distributions from the trustee reported 
on an accrual basis?
9
No N/A
Yes No N/A
4. Is the right to future income and the 
principal held in trust disclosed in the 
notes, if appropriate?
5. If the trustee made a discretionary 
distribution, did the entity report the 
distribution in accordance with the terms of 
the trust or the agreement with the trustee? 
[AAG-HEA, sec. 3.15]
6. If the reporting entity is the remainderman, 
were the donated funds reported as assets of 
the entity (depending on the terms of the 
trust document)?
[AAG-HEA, sec. 3.16]
D. Timing Differences
1. Are timing differences recognized in the 
periods in which they arise and reverse?
2. Are permanent differences excluded from the 
interperiod reimbursement allocation? 
[AAG-HEA, sec. 3.17]
3. Is the effect of timing differences related 
to reimbursement programs that became 
permanent reported in the period in which it 
was determined that they will not be 
recovered or realized?
[AAG-HEA, sec. 3.18]
E. Health Care Entities as a Part of Other 
Organizations
1. Were the recommendations contained in the 
Guide applied to the separate financial 
statements of all health care entities 
(other than state and local government-owned 
entities that do not use enterprise fund 
accounting and reporting)?
2. Were the effects of GASB pronouncements 
considered?
[AAG-HEA, sec. 3.22]
F. Financial Statements
10
Yes No N/A
1. For not-for-profit and governmental
providers, do the basic financial statements 
include:
a. A balance sheet?
b. A statement of revenue and expenses of
general funds? _____
c. A statement of changes in fund balances? _____
d. A statement of cash flows of general funds
(and restricted funds of governmental 
entities)? _____
2. For investor-owned providers, are the basic 
financial statements similar to those of 
other investor-owned entities?
[AAG-HEA, sec. 3.24] _____
3. Were the provisions of SFAS No. 95 (or GASB 
Statement No. 9) applied (using either the 
direct or indirect method of reporting cash 
flows)?
[AAG-HEA, sec. 3.25] _____
II. SCOPE OF THE ENGAGEMENT
A. Special-Purpose Reports
1. Has a clear understanding (preferably in 
writing) with the client been established 
regarding services and responsibilities for:
a. Cost reports? _____
b. Reports for:
(1).  Contributors? _____
(2).  Federal, state or local authorities? _____
c. Other special-purpose reports?
[AAG-HEA, sec. 4.1] _____
III. CASH AND CASH EQUIVALENTS
A. Accounting and Financial Statement 
Presentation
11
Yes
1. Operating accounts
a. Does cash on hand consist of money in the 
possession of cashiers receiving payments 
from:
(1).  Inpatients, outpatients, or residents? _____
(2).  Gift shops, parking lots, and
cafeterias?
(3).  Other collection points?
b. Are petty cash funds included in cash on 
hand?
[AAG-HEA, sec. 5.2]
c. Are there checking accounts used to 
deposit daily receipts and to make 
disbursements or transfers to other 
accounts?
[AAG-HEA, sec. 5.3]
d. Are there time deposits or similar 
accounts?
[AAG-HEA, sec. 5.4]
2. Are separate accounts maintained for 
restricted cash and cash equivalents? 
[AAG-HEA, sec. 5.5]
3. Personal fund accounts
a. Are personal funds reported as assets and 
corresponding liabilities in the balance 
sheet?
b. Is the amount of personal funds reported 
as assets disclosed parenthetically on the 
balance sheet or in the notes?
[AAG-HEA, sec. 5.6]
4. Is the policy for determining cash 
equivalents disclosed?
[SFAS 95, par. 10 (CT, sec. C25.107)]
IV. INVESTMENTS
12
No N/A
Yes
A. Accounting and Financial Statement 
Presentation
1. General
a. Were investments initially recorded at 
acquisition cost or, if donated, at fair 
market value at the date of donation?
b. Are investments of general funds 
reported as current or noncurrent assets 
in conformity with generally accepted 
accounting principles?
[AAG-HEA, sec. 6.1]
c. Are equity securities reported at the 
lower of aggregate cost or market value? 
[SFAS No. 12 (CT, sec. I89)]
d. Are debt securities reported at amortized 
cost if there is the intent and ability to 
hold to maturity, or at lower of cost or 
market if not intended to be held to 
maturity?
(1).  If the market value is less than cost
and the impairment in value is deemed to 
be other than temporary, are the 
investments reported at an amount not to 
exceed market value?
[AAG-HEA, sec. 6.2a]
e. Are unconsolidated affiliates (e.g. joint 
ventures) accounted for using the equity 
method of accounting and reported in 
accordance with APB No. 18?
[CT, sec. I82]
f. Are other securities (e.g. real estate and 
oil and gas interests) reported at 
amortized cost, or at market value if an 
impairment in value is deemed to be other 
than temporary?
[AAG-HEA, sec. 6.2c]
2. Investment pools
a. Does the not-for-profit health care entity
13
No N/A
Yes
use the market-value method to equitably 
allocate investment income (including 
gains and losses) of investment pools? 
[AAG-HEA, sec. 6.4]
3. Marketable equity securities
a. Are the marketable equity portfolios of 
the not-for-profit health care entity 
reported at the lower of aggregate cost or 
market value determined at the balance 
sheet date?
b. Are the amounts by which the aggregate 
cost of each portfolio exceeds market 
value reported as valuation allowances 
(unless the decline in market value is 
judged to be other than temporary)?
c. Are the marketable equity securities 
grouped into separate portfolios for the 
purpose of comparing aggregate cost and 
market value to determine the amount to be 
reported on the financial statements?
[SFAS No. 12 (CT, sec. I89)]
(1).  Are marketable equity securities
included in general funds grouped into 
separate portfolios according to the 
current or noncurrent classification of 
the securities?
(2).  Are marketable equity securities
included in donor-restricted funds
grouped into separate portfolios
according to the type of fund? (For
example, portfolios of marketable equity
securities included in various
specific-purpose funds are grouped
together, but not with those of
endowment funds.) _____
(3).  Are the current and noncurrent
portfolios of general funds of entities 
that are consolidated or combined each 
treated as a single combined portfolio? _____
(4).  Are portfolios of similar
14
No N/A
Yes No N/A
donor-restricted funds of consolidated 
or combined entities treated as a single 
portfolio?
[AAG-HEA, sec. 6.7] _____
d. If there is a change between current and 
noncurrent assets classification of a 
marketable equity security included in 
general funds, was the security 
transferred at the lower of its cost or 
market value at the date of the transfer? _____
(1).  If market value is less than cost, was 
the difference accounted for as if it 
were a realized loss?
(2).  If investments are pooled, was the cost 
of the securities compared to the 
allocation of the market value of the 
pooled marketable equity securities 
(accounting separately for the 
securities from other investments)? 
[AAG-HEA, sec. 6.8]
e. Is the following information disclosed
(either in the financial statements or in 
the accompanying notes):
(1).  As of the date of each balance sheet 
presented, aggregate cost and market 
values for each portfolio into which 
marketable equity securities are grouped 
to determine the carrying amount, with 
identification as to which is the 
carrying amount?
(2).  As of the date of the latest balance 
sheet presented, the following, 
segregated by portfolio:
(a). Gross unrealized gains, representing 
the excess of market value over cost, 
for all marketable equity securities 
in the portfolio having such an 
excess?
(b). Gross unrealized losses, representing 
the excess of cost over market value,
15
Yes No N/A
for all marketable equity securities 
in the portfolio having such an 
excess?
(3).  For each period for which a statement of 
revenues and expenses is presented:
(a). Net realized gain or loss included in
the statement of revenues and 
expenses?
(b). The basis on which cost was determined
in calculating realized gain or loss 
(average cost or other method used)? 
[AAG-HEA, sec. 6.9]
f. Were the financial statements not adjusted 
for subsequent event-type realized gains 
or losses, or changes in market prices of 
marketable equity securities, except for 
non-temporary declines?
(1).  Were subsequent net realized and
unrealized marketable equity security 
gains and losses disclosed if 
significant?
[AAG-HEA, sec. 6.10 (AU secs. 560.05 
and .07)]
g. For those marketable securities whose 
change in carrying amount is included in 
the statement of changes in fund balances 
(see j. below) and whose decline in value 
is judged to be other than temporary:
(1).  Were the individual bases adjusted down
to the market value at the balance sheet 
date?
(2).  Were the amounts of the adjustments
reported as a realized loss?
(3).  Were the new bases not changed for
subsequent recoveries in market value? 
[AAG-HEA, sec. 6.11]
h. Was a loss recognized because of a change 
in classification between current and
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Yes No N/A
noncurrent assets in general funds 
reported in the statement of revenue and 
expenses?
i. Was the change in the valuation allowance 
for a portfolio included in current 
assets in general funds disclosed and 
reported in the statement of revenues 
and expenses?
j. For a portfolio included in noncurrent 
assets in general funds or assets in 
restricted funds, was the change in the 
valuation allowance disclosed and reported 
in the respective statement of changes in 
fund balances?
k. Were accumulated changes in the valuation 
allowance for such portfolios disclosed 
and reported in the appropriate fund 
balance in the balance sheet?
[AAG-HEA, sec. 6.12]
l. Were realized gains or losses on the sale 
of investments of endowment funds added to 
or deducted from the funds' principal 
(unless such amounts were legally 
available for other use or chargeable to 
other funds)?
(1).  Was investment income accounted for in 
accordance with the donors' 
instructions?
[AAG-HEA, sec. 6.13]
m. Were income and net realized gains or 
losses on investments of restricted funds 
(other than endowment funds) added to or 
deducted from the respective fund balance 
(unless such amounts were legally 
available for other use or chargeable to 
other funds)?
(1).  If such amounts are legally available 
for unrestricted purposes, are they 
reported in the statement of revenues 
and expenses?
17
Yes No N/A
(2).  Were gains or losses on investment
trading between general and restricted 
funds and between various categories of 
restricted funds recognized as realized 
gains or losses and separately disclosed 
in the financial statements?
(3).  Were gains or losses not recognized if 
they resulted from transactions between 
various portfolios classified as assets 
whose use is limited in the general 
funds section of the balance sheet? 
[AAG-HEA, sec. 6.14]
n. Were no adjustments due to unrealized 
gains or losses made to the reported 
value of investments classified as 
noncurrent (except for changes in the 
valuation allowance related to marketable 
equity securities and for declines in 
value that result from
other-than-temporary impairment)? 
[AAG-HEA, sec. 6.15]
V. RECEIVABLES
A. Accounts Receivable for Health Care Services
1. Were revenue and the related receivables 
recorded on an accrual basis at the 
provider's full established rates?
a. Were the provisions for contractual 
adjustments, discounts and other 
uncollectibles recorded on an accrual 
basis?
b. Were the above provisions deducted from 
gross service revenue to determine net 
service revenue?
c. Were the related allowances recorded to 
report the receivables at net realizable 
value?
d. Were the above provisions reported in the 
period that the services were provided? 
[AAG-HEA, sec. 7.4]
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Yes No N/A
e. Were all charity care revenue and
receivables excluded from the financial 
statements?
[AAG-HEA, sec. 7.2)
2. Does the provider have a method to properly 
estimate the revenue earned for individuals 
covered under a prospective payment system 
(PPS) who are institutionalized at the 
balance sheet date?
a. Does the provider have a method to record 
an estimated contractual adjustment to 
report the related receivables at net 
realizable value?
b. Does the methodology used properly match 
revenue with costs?
[AAG-HEA, sec. 7.5] _____
3. Are you familiar with the rate-setting
environment in which the entity operates? _____
a. Are you familiar with the regulations and 
contractual agreements that determine 
payments to be received for health care 
services?
[AAG-HEA, sec. 7.6] _____
b. Are you aware that some rate-setting 
methods described as prospective may 
include provision for retrospective 
adjustments?
c. Are you aware that some third parties pay 
prospective rates for certain services and 
retrospective rates for others?
[AAG-HEA, sec. 7.7]
4. Are estimated final settlements reported in 
the financial statements in the period in 
which services are rendered?
a. Are differences between the estimates
originally reported and interim and final 
settlements included in the statement of 
revenue and expenses in the period the 
settlements are made?
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Yes No N/A
b. Are those differences not treated as prior 
period adjustments (unless they meet the 
criteria as set forth in SFAS No. 16,
Prior Period Adjustments?)
[AAG-HEA, sec. 7.9]
5. Are rate-setting methods that are described 
as prospective but provide for retrospective 
adjustments accounted for as retrospective 
rate-setting systems for the services to 
which they apply?
[AAG-HEA, sec. 7.10]
6. Are advances from third-party payers 
reported as a liability (unless the right of 
setoff against a related receivable 
applies)?
[AAG-HEA, sec. 7.11]
7. Are deposits received from individuals 
reported as a liability (to the extent that 
a right of setoff does not exist)?
[AAG-HEA, sec. 7.12]
8. Were pending appeals accounted for in 
accordance with SFAS No. 5, Accounting for 
Contingencies, as amended and interpreted? 
[CT, sec. C59]
9. Were state waiver contingencies under 
Medicare accounted for in accordance with 
SFAS No. 5, as above?
[AAG-HEA, sec. 7.14]
B. Premiums and Stop-Loss Insurance Receivables
1. Were stop-loss insurance costs accounted for 
in accordance with SOP 89-5?
[AAG-HEA, sec. 7.15]
C. Financial Statement Presentation and 
Disclosure
1. Were the receivables (less an allowance for 
uncollectibles, discounts, and contractual 
adjustments) reported as current assets in 
the general funds?
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Yes No N/A
a. If the terms of payment have been extended 
beyond one year of the balance sheet date,
was that portion classified as noncurrent? _____
b. Are amounts due from third-party payers 
for retroactive adjustments reported 
separately?
[AAG-HEA, sec. 7.16] _____
2. If the financial statements present assets
and liabilities by fund groups, were 
interfund receivables or payables reported 
separately by fund? _____
a. Were they classified as current or
noncurrent in general funds? _____
b. If the financial statements do not present
assets and liabilities by fund groups, 
were interfund receivables and payables 
eliminated by adjusting the related cash 
and investment accounts in order to report 
those accounts as if the cash or 
investments had been actually exchanged? _____
3. If a formal interfund borrowing agreement 
exists, were the circumstances and terms of 
the borrowing agreement disclosed?
[AAG-HEA, sec. 7.17] _____
4. Were pledges reported in the period in which
they were made? _____
a. Are pledges reported net of an allowance 
for uncollectible amounts?
b. Are unrestricted pledges reported in the 
statement of revenue and expenses?
c. If part of a pledge is to be applied 
during some future period, was that part 
reported in the general fund in the period 
in which it was received as deferred 
revenue or, if restricted, as an addition 
to donor-restricted funds?
d. If pledges were restricted in any other 
way, are they reported as additions to
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Yes No N/A
donor-restricted funds?
[AAG-HEA, sec. 7.18]
5. Are other receivables reported net of the
related allowance for uncollectible amounts? 
[AAG-HEA, sec. 7.19]
VI. PROPERTY AND EQUIPMENT, SUPPLIES, AND OTHER
ASSETS
A. Accounting
1. Are the useful lives assigned to depreciable 
assets- reasonable?
B. Financial Statement Presentation
1. Is the property and equipment of the 
provider using fund accounting reported in 
the general funds (except as indicated in 
no. 4 below)?
2. Is property of general funds not used for 
operations presented separately?
3. Are donor or legal restrictions on the 
proceeds from the disposition of property 
and equipment disclosed?
[AAG-HEA, sec. 8.6]
4. Is property and equipment of 
donor-restricted funds reported in the 
appropriate donor-restricted fund?
[AAG-HEA, sec. 8.7]
5. Is the. financial statement presentation of 
supplies and other assets similar to that of 
other business organizations?
[AAG-HEA, sec. 8.8]
VII. CURRENT LIABILITIES AND LONG-TERM OBLIGATIONS
A. Accounting
1. General
a. Are liabilities related to compensated
absences accounted for in accordance with
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Yes
SFAS No. 43, Accounting for Compensated 
Absences?
[CT, sec. C44] _____
b. Did the not-for-profit provider report 
tax-exempt obligations that were issued 
for its benefit as liabilities in the 
general funds?
[AAG-HEA, sec. 9.4] _____
c. If new obligations were incurred in an 
advance refunding or for early retirement 
or extinguishment of debt, were the 
transactions recorded in accordance with 
SFAS No. 4, Reporting Gains and Losses 
from Extinguishment of Debt, as amended, 
and SFAS No. 76, Extinguishment of Debt?
[CT, sec. D14] _____
2. Continuing Care Retirement Communities 
(CCRCs)
a. If advance fees and periodic fees are 
insufficient to meet a CCRC's costs of 
providing future services to and use of 
facilities by current residents, are 
liabilities accrued and reported 
currently?
[AAG-HEA, sec. 9.9] _____
B. Tax Considerations for Not-for-Profit Health
Care Entities
1. Entities owned and operated by state and 
local governments
a. Has the entity’s management given
consideration to the preservation of 
qualification of its tax-exempt status? _____
2. Tax-exempt entities
a. Was no part of the entity's net earnings, 
directly or indirectly, inured to any 
private shareholder or individual? _____
b. Was no substantial part of its activities 
carrying on propaganda or otherwise 
attempting to influence legislation?
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No N/A
Yes
c. Has the entity not participated in any 
political campaign on behalf of any 
candidate for public office?
[AAG-HEA, sec. 9.13]
d. Was the entity organized as a nonprofit 
charitable organization for the purpose of 
operating a hospital for the care of the 
sick?
e. Is the entity operated for the care of all 
persons able to pay (directly or 
indirectly)?
f. Does the entity not restrict the use of 
its facilities to a particular group of 
physicians or surgeons to the exclusion of 
other qualified doctors?
g. Does the entity not permit any of its 
earnings to benefit (directly or 
indirectly) any private individual? 
[AAG-HEA, sec. 9.15]
h. If the entity is a nursing home, is it 
operated to meet the primary needs of the 
elderly for housing, health care, and 
financial security?
[AAG-HEA, sec. 9.16]
3. Determination of tax-exempt status
a. Did the auditor obtain a copy of the 
ruling or latest determination letter 
received from the IRS to determine if the 
entity qualifies as a Section 501(c)(3) 
organization?
(1).  If the original letter was dated prior
to October 9, 1969, did the auditor 
obtain a copy of the determination 
letter that indicates that the entity is 
not a private foundation as described in 
Section 509(a)?
(2).  Editor’s note—Private foundations are
subject to an excise tax on investment 
income and must file Form 990-PF. 
[AAG-HEA, sec. 9.18]
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No N/A
Yes No N/A
b. Did the auditor consider obtaining a copy 
of any revenue agent’s reports issued 
during the past year?
(1).  Did the auditor discuss the current
status of any open IRS examinations with 
the entity's management?
(2).  Did the auditor consider the effects, if
any, of current and prior examinations 
on the financial statements and 
disclosures related to the existence of 
contingent liabilities for unrelated 
business income tax, additional payroll 
tax liabilities, or penalties and 
interest on delinquent taxes?
[AAG-HEA, sec. 9.19]
c. Was the auditor alert for changes in the 
governing instruments that could affect 
the entity's tax-exempt status?
(1).  Did the auditor review the minutes for 
the current year and discuss with 
management whether the entity has 
engaged in any new or unusual activities 
that could affect its tax-exempt status? 
[AAG-HEA, sec. 9.20]
d. Was appropriate written representation 
obtained from management regarding tax 
matters?
e. Is disclosure appropriate regarding the 
entity's tax-exempt status and any other 
significant tax matters?
[AAG-HEA, sec. 9.21]
4. Unrelated business income tax
a. Were the exclusions from the unrelated 
business income tax considered?
[AAG-HEA, sec. 9.23]
b. If the provider operates a pharmacy in a 
medical office building for the 
convenience of the physicians' private 
patients, were the earnings considered 
taxable?
[AAG-HEA, sec. 9.25]
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Yes No N/A
c. If an entity operates a gift shop or 
cafeteria that is primarily patronized by 
patients, visitors, and employees, was the 
operation not classified as unrelated? 
[AAG-HEA, sec. 9.26]
d. Was income attributable to the use of a 
parking lot by patients, visitors, and 
employees, considered exempt from 
unrelated business income tax?
[AAG-HEA, sec. 9.27]
e. Was a determination made of the taxability 
of rental income received by not-for- 
profit providers leasing property they 
own?
[AAG-HEA, sec. 9.28]
f. Were all direct and indirect expenses 
identified and charged or allocated (on an 
appropriate basis) to the taxable 
activities?
(1). Was unrelated business taxable income 
reported annually on Form 990-T? 
[AAG-HEA, sec. 9.29]
g. Was consideration given to the generation 
of unrelated business taxable income from 
business dealings with affiliates? 
[AAG-HEA, sec. 9.30 -.31]
h. Was consideration given to the taxability 
of the provider’s passive income from 
affiliates?
[AAG-HEA, sec. 9.32]
5. Arbitrage restrictions
a. Was consideration given to the effects of 
the Tax Reform Act of 1986 which added new 
arbitrage restrictions?
[AAG-HEA, sec. 9.33]
C. Financial Statement Presentation
1. Is the provider’s reporting and disclosure 
regarding current liabilities and long-term
26
Yes
obligations similar to that of other 
businesses?
2. For CCRCs, are the following disclosed:
a. Method of accounting for advance fees?
b. Method of calculating the obligation to 
provide future services and use of 
facilities?
c. Refund policy for refundable fees? 
[AAG-HEA, sec. 9.34]
VIII. COMMITMENTS AND CONTINGENCIES
A. Accounting for Uninsured Asserted and
Unasserted Medical Malpractice Claims
1. Were the ultimate costs of malpractice 
claims (including costs associated with 
litigating or settling claims) accrued when 
the incidents occurred that gave rise to the 
claims (if probable and reasonably 
estimable)?
[AAG-HEA, sec. 10.3]
2. If the information available indicates the 
loss is within a range, was the most likely 
amount in the range accrued?
a. If no amount in the range is more likely 
than any other, was the minimum amount 
accrued?
b. Was any potential additional loss 
disclosed if there is a reasonable 
possibility of loss in excess of the 
amount accrued?
c. If the range of loss cannot be reasonably 
estimated, was no loss accrued?
[AAG-HEA, sec. 10.4]
3. Were estimated losses reviewed and changed, 
if necessary, at each reporting date?
a. Were the amounts of the changes recognized
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No N/A
Yes
currently as additional expense or 
reductions of expense?
[AAG-HEA, sec. 10.5]
4. Were estimated losses from asserted claims 
accrued (individually or on a group basis) 
based on the best estimates of the ultimate 
costs of the claims?
a. Were estimated losses from unasserted 
claims arising from reported incidents 
accrued (individually or on group basis) 
using the relationship of past reported 
incidents to eventual claim payments?
b. Was all relevant information used in 
estimating the expected amount of asserted 
and unasserted claims arising from 
reported incidents?
[AAG-HEA, sec. 10.6]
5. Did the provider accrue estimated losses 
from unreported incidents based on its best 
estimate of the ultimate costs?
a. Were the estimates based on all available 
evidence relevant to estimating unreported 
incidents that have occurred as well as 
the amount of loss related to those 
estimated incidents?
b. Was the accrual limited to an estimate of 
the losses that will result from 
unreported incidents that are probable of 
having occurred before the end of the 
reporting period?
[AAG-HEA, sec. 10.7]
6. If industry data is used to estimate 
malpractice claim losses, does such data 
possess the following characteristics?
a. Comparability with client operations and 
environment?
b. Is it current?
[AAG-HEA, sec. 10.9]
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No N/A
Yes No N/A
7. Are accrued unpaid claims and expenses 
expected to be paid during the normal 
operating cycle classified as current 
liabilities?
a. Are all other accrued unpaid claims and 
expenses classified as noncurrent? 
[AAG-HEA, sec. 10.10]
8. Is the program of medical malpractice 
insurance coverages disclosed?
a. Is the basis for any related loss accruals 
disclosed?
b. If the losses relating to a particular 
category of malpractice claims cannot be 
estimated, was no loss accrued and the 
contingency disclosed?
[AAG-HEA, sec. 10.11 and CT, sec. C59]
9. If the provider discounts accrued 
malpractice claims, is the carrying amount 
of accrued malpractice claims disclosed?
a. Are the interest rates used to discount 
the claims disclosed?
[AAG-HEA, sec. 10.12]
B. Accounting for Claims-Made Insurance Policies 
and Tail Coverage
1. Was the estimated cost of those claims and 
incidents not reported to the insurance 
carrier recognized (unless the provider 
bought tail coverage and included the cost 
of the premium as an expense for that 
period)?
[AAG-HEA, sec. 10.13]
2. If the subsequent renewal of a claims-made 
policy or purchase of tail coverage limits 
the entity’s liability exposure as of the 
balance sheet date, has the accrual for 
incurred-but-not-reported (IBNR) claims been 
adjusted accordingly?
[AAG-HEA, sec. 10.29]
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Yes No N/A
3. If the entity has a unilateral option to 
purchase tail coverage at a premium not to 
exceed a stipulated maximum, and it intends 
to purchase that coverage, has the IBNR loss 
accrual been limited to the maximum stated 
in a policy?
[AAG-HEA, sec. 10.31]
C. Accounting for Retrospectively Rated Premiums
1. If the provider cannot estimate losses from 
asserted or unasserted malpractice claims, 
was the existing contingency disclosed? 
[AAG-HEA, sec. 10.14 and CT, sec. C59]
2. For providers insured under a 
retrospectively rated policy, was the 
initial premium amortized to expense pro 
rata over the policy term?
a. Were additional premiums or refunds 
accrued?
b. Did the provider disclose that it is 
insured under a retrospectively rated 
policy?
c. Did the provider disclose that premiums 
are accrued based on the ultimate cost of 
the experience to date of a group of 
entities?
d. If the losses cannot be estimated, is the 
existing contingency disclosed?
[AAG-HEA, sec. 10.15 and CT, sec. C59]
D. Accounting for Medical Malpractice Claims
Insured with Captive Insurance Companies
1. Are captive insurance companies accounted 
for in accordance with SFAS No. 94, 
Consolidation of all Majority-Owned
Subsidiaries [CT, sec. C51], or APB 
Opinion No. 18, The Equity Method of 
Accounting for Investments in Common Stock
[CT, sec. 182], as applicable?
[AAG-HEA, sec. 10.16]
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Yes No N/A
2. For providers insured by a consolidated 
captive, do the financial statements include 
a provision for estimated losses from 
asserted or unasserted malpractice claims? 
[CT, sec. C59]
3. Did the provider account for malpractice 
insurance (based on its own experience) by 
an unconsolidated multiprovider captive as 
described in C.1. above?
[AAG-HEA, sec. 10.17]
4. Did the provider account for malpractice 
insurance (based on a group’s experience) by 
an unconsolidated multiprovider captive as 
described in C.2. above?
a. Was the ability of the multiprovider 
captive to relieve the provider from
further liability considered? _____
b. Did the provider disclose that it is 
insured under a retrospectively rated
policy of a multiprovider captive? _____
c. Did the provider disclose that premiums 
are accrued based on the captive’s 
experience to date?
[AAG-HEA, sec. 10.18] _____
d. Was the fact that the provider is insured
by a multiprovider captive disclosed? _____
(1).  Was the provider’s ownership percentage
in the captive disclosed? _____
(2).  Was the method of accounting for its
investment in and the operations of the 
captive disclosed? _____
(3).  If the provider cannot make the
necessary estimates of losses from 
asserted or unasserted claims, did it 
disclose the existing contingency?
[AAG-HEA, sec. 10.19 and CT, sec. C59] _____
E. Accounting for Trust Funds
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Yes No N/A
1. Are trust funds (revocable or irrevocable) 
included in the provider’s financial 
statements?
a. Is a portion of the fund (the amount of 
assets expected to be liquidated to pay 
malpractice claims classified as current 
liabilities) classified as a current 
asset?
(1).  Is the balance, if any, classified as a
noncurrent asset?
(2).  Are trust fund revenue and
administrative expenses included in the 
statement of revenue and expenses? 
[AAG-HEA, sec. 10.20]
b. Are estimated losses from asserted and 
unasserted claims accrued and reported? 
[AAG-HEA, sec. 10.21]
c. Is the existence of the trust fund and 
whether or not it is revocable disclosed? 
[AAG-HEA, sec. 10.22]
F. (Reserved)
G. Disclosures
1. Were disclosures for other commitments and 
contingent liabilities similar to those of 
other business organizations?
[AAG-HEA, sec. 10.25]
IX. NET ASSETS (EQUITY OR FUND BALANCE)
A. Financial Statement Presentation
1. Are the equity accounts of an investor-owned 
provider accounted for similarly to other 
investor-owned businesses?
2. Are the net assets of not-for-profit and 
governmental providers (that use the 
disaggregated method) displayed as general 
and donor-restricted fund balances?
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Yes No N/A
3. Are the net assets of not-for-profit and 
governmental providers (that use the 
aggregated method) displayed as 
unrestricted, temporarily restricted or 
permanently restricted fund balances as 
appropriate?
[AAG-HEA, sec. 11.1]
4. Is the nature of restrictions on 
donor-restricted resources disclosed? 
[AAG-HEA, sec. 11.2]
X. REVENUE, EXPENSES, GAINS, AND LOSSES
A. Conceptual Framework for Reporting and 
Classification
1. Are revenues and expenses (arising from 
ongoing activities associated with health 
care services) classified as operating and 
displayed as gross amounts?
2. Are gains and losses resulting from 
peripheral or incidental transactions and 
from other events (environmentally related 
and largely uncontrollable) displayed as net 
amounts?
[AAG-HEA, secs. 12.1 -.2]
3. Are gains and losses classified as to their 
relation to major ongoing or central 
operations?
a. Operating if related?
b. Nonoperating if peripheral, incidental or 
unrelated?
[AAG-HEA, sec. 12.3]
B. Revenue
1. Was revenue from health care services 
recorded when the service was provided?
2. Was the revenue classified based on the type 
of service rendered or contracted to be 
rendered?
[AAG-HEA, sec. 12.4]
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Yes
3. Were contributions, tax support and other 
subsidies classified as:
a. Gains, when peripheral or incidental to 
health care activities?
b. Revenues, if deemed ongoing major or 
central activities to provide health care 
services?
[AAG-HEA, sec. 12.5]
4. Was other normal revenue (including revenue 
from sales and non-health care services to 
patients, residents, nonpatients or 
visitors) classified as operating?
5. Was this other revenue accounted for 
separately from revenue from providing 
health care services?
[AAG-HEA, secs. 12.6 -.7]
C. Gains and Losses
1. Have gains and losses been properly 
classified and reported?
[AAG-HEA, sec. 12.8]
D. Expenses
1. Was the basis and timing of the recognition 
of expenses the same as for business 
organizations?
[AAG-HEA, sec. 12.9]
E. Financial Statement Presentation
1. Is service revenue reported net of 
contractual and other adjustments in the 
statement of revenue and expenses?
[AAG-HEA, sec. 12.11]
2. Do the disclosures include:
a. Revenue recognition method?
b. Explanation and amount of charity care 
provided?
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No N/A
Yes No N/A
c. Method of recording unrestricted and
restricted donations and investment income 
of both general and restricted funds?
3. With regard to contractual adjustments and 
third-party settlements, did the provider 
identify and explain the estimated amounts 
payable or receivable?
[AAG-HEA, sec. 12.13]
4. Were the expense classifications and 
subclassifications appropriate (considering 
the size of the entity, comparability with 
other entities and any other significant 
factors)?
5. Were bad debts included in expenses rather 
than as a reduction of revenue?
[AAG-HEA, sec. 12.14]
6. Were expenses incurred to solicit 
contributions separately disclosed?
[AAG-HEA, sec. 12.16]
XI. REPORTING ENTITY AND RELATED ORGANIZATIONS
A. Financial Reporting
1. If the entity is related to a separate 
organization and meets the criteria stated 
in ARB No. 51, Consolidated Financial 
Statements, as amended by SFAS No. 94, 
Consolidation of all Majority-Owned 
Subsidiaries, did it consolidate or combine 
in accordance with such pronouncements?
[CT, sec. C51]
2. Has the information about unconsolidated 
subsidiaries required by APB No. 18, The 
Equity Method of Accounting for Investments
in Common Stock, continued to be disclosed 
for subsidiaries now consolidated under SFAS 
No. 94, but previously unconsolidated? 
[AAG-HEA, sec. 13.2 (CT, sec. I82)]
3. If the entity does not meet the criteria 
stated in ARB No. 51, as amended by SFAS No. 
94, but controls and is the sole beneficiary
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Yes No N/A
of the related organization’s activities, 
did it disclose summarized financial data of 
the related organization?
[AAG-HEA, secs. 13.3 -.4]
4. For any organization which the health care 
entity controls or is the sole beneficiary 
of, but which is not consolidated or 
combined, did the entity disclose:
a. The nature of the relationship between the 
entity and the organization?
b. If there have been material transactions 
between the entity and the organization:
(1).  The amount and description of such
transactions?
(2).  Amounts due from or to the organization,
and the terms and manner of settlement 
(if not apparent)?
[AAG-HEA, sec. 13.5]
5. Were related party disclosures made in 
accordance with SFAS No. 57, Related Party 
Disclosures?
[CT, sec. R36]
XII. SOP 89-5, FINANCIAL ACCOUNTING AND REPORTING BY
PROVIDERS OF PREPAID HEALTH CARE SERVICES
A. Accounting for Health Care Costs
1. Are health care costs accrued as the 
services are rendered?
2. Are estimates of the costs of services 
rendered but not yet reported accrued?
3. If a provider is obligated to render 
services beyond the premium period, are the 
costs to be incurred accrued currently?
4. Are costs that will be incurred after a 
contract is terminated (such as guaranteed 
salaries, rent, and depreciation, net of any 
related anticipated revenues) accrued when
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Yes
it is determined that a contract with a 
sponsoring employer or other group will be 
terminated?
[SOP 89-5, par. 30]
5. Are amounts payable to hospitals, 
physicians, or other providers under 
risk-retention, bonus, or similar programs 
accrued during the contract period based on 
relevant factors (such as experience to 
date)?
[SOP 89-5, par. 31]
6. Is the basis for accruing health care costs 
disclosed?
7. Are significant business and contractual
arrangements with hospitals, physicians, and 
other associated entities disclosed?
[SOP 89-5, par. 32]
B. Accounting for Loss Contracts
1. Is a loss recognized when it is probable 
that expected future health care and 
maintenance costs under a group of existing 
contracts will exceed anticipated future 
premiums and stop-loss insurance recoveries 
on those contracts?
2. Did the above costs include fixed and 
variable, direct and allocable indirect 
costs?
3. Were contracts grouped in a manner
consistent with the provider's method of 
establishing premium rates to determine 
whether a loss has been incurred?
[SOP 89-5, par. 41]
C. Accounting for Stop-Loss Insurance
1. Were stop-loss insurance premiums included 
in reported health care costs?
2. Were stop-loss insurance recoveries reported
as reductions of related health care costs? _____
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No N/A
Yes No N/A
3. Were receivables representing amounts 
recoverable from insurers reported as 
assets?
4. Were the above receivables reduced by 
appropriate valuation allowances?
5. Were the nature, amounts, and effects of 
significant stop-loss insurance contracts 
disclosed?
[SOP 89-5, par. 49]
D. Accounting for Contract Acquisition Costs
1. Were acquisition costs of providers of 
prepaid health care services expensed as 
incurred?
[SOP 89-5, par. 54]
XIII. SFAS 105, DISCLOSURE OF INFORMATION ABOUT
FINANCIAL INSTRUMENTS WITH OFF-BALANCE-SHEET
RISK AND FINANCIAL INSTRUMENTS WITH
CONCENTRATIONS OF CREDIT RISK
A. Financial Reporting
1. Except for certain items excluded in SFAS 
105, paragraphs 14 and 15 [CT F25.104 and 
.105], were the following disclosed in the 
financial statements or notes for each class 
(as determined by codification or 
conventional usage) of financial instruments 
with off-balance-sheet risk (including 
a) cash, b) an equity interest, or 
c) a contract that requires a transfer or 
exchange of cash or another financial 
instrument between two entities on terms 
that favor one entity over another)?
a. The face or contract amount, or notional 
principal amount if there is no face or 
contract amount?
b. The nature and terms, including, at a 
minimum, a discussion of the following:
(1). Credit and market risk of those 
instruments?
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(2).  Cash requirements of those instruments? _____
(3).  Related accounting policy, as required
by APB Opinion No. 22, Disclosure of 
Accounting Policies?
[SFAS 105, par. 17 (CT F25.112)] _____
2. For financial instruments with off-balance- 
sheet credit risk (except for the items 
excluded in SFAS 105, paragraphs 14 and 15 
[CT F25.104 and .105]), were the following 
disclosed either in the financial statements 
or notes by class of financial instrument:
a. The amount of accounting loss the entity 
would incur if 1) any party to the 
financial instrument failed completely to 
perform according to the terms of the 
contract, and 2) the collateral or other 
security, if any, for the amount due
proved to be of no value to the entity? _____
b. Regarding collateral or other security to 
support financial instruments subject to 
credit risk:
(1).  The entity’s policy of requiring such
collateral or other security? _____
(2).  Information about the entity’s access to
that collateral or other security? _____
(3).  The nature and a brief description of
the collateral or other security 
supporting those financial instruments?
[SFAS 105, par. 18 (CT F25.113)] _____
(4).  Has the entity considered disclosing
additional information about the extent 
of that collateral or other security?
[SFAS 105, par. 19 (CT F25.114)] _____
3. Did disclosures of all significant 
concentrations of credit risk arising from 
all financial instruments, whether from an 
individual counterparty or groups of 
counterparties (except for certain insurance 
and investment contracts, purchase and
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Yes No N/A
pension obligations and substantively 
extinguished debt noted in SFAS 105, 
paragraph 14 [CT F25.104]), include the 
following:
a. Information about the (shared) activity, 
region, or economic characteristic that 
identifies the concentration?
b. The amount of the accounting loss due to 
credit risk the entity would incur if 1) 
parties to the financial instruments that 
make up the concentration failed 
completely to perform according to the 
terms of the contracts and 2) the 
collateral or other security, if any, for 
the amount due proved to be of no value to 
the entity?
c. Regarding collateral or other security to 
support financial instruments subject to 
credit risk:
(1).  The entity's policy of requiring such
collateral or other security?
(2).  Information about the entity's access to
that collateral or other security?
(3).  The nature and a brief description of
the collateral or other security 
supporting those financial instruments? 
[SFAS 105, par. 20 (CT F25.115)]
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REPORTING CHECKLISTS
These checklists have been developed by the staff of the Technical 
Information Division of the AICPA as nonauthoritative practice aids
Yes No
A. AUDIT REPORTS
1. Does the auditor’s report include appropriate:
a. Addressee?
[SAS 58, par. 9 (AU 508.09)]
b. Date (or dual dates) of the report?
[SAS 1, sec. 530 (AU 530); SAS 26, pars. 
15-17 (AU 504.15-.17); SAS 58, par. 74 
(AU 508.74)]
c. Title that includes the word "independent"? 
[SAS 58, par. 8 (AU 508.08)]
2. If the accountant is not independent, 
regardless of the extent of services proved, 
has the appropriate disclaimer been expressed 
provided?
[SAS 26, pars. 8-9 (AU 504.08-.09)]
a. For a public entity?
[SAS 26, par. 10 (AU 504.10)]
b. For a nonpublic entity?
[SSARS 1, pars. 22 and 38 (AR 100.22 and 
.38)]
3. Does the reporting language conform with the 
auditor’s standard report on:
a. Financial statements of a single year or 
period?
b. Comparative financial statements?
[SAS 58, par. 8 (AU 508.08)]
4. Does the report include appropriate language 
in respect of the following:
a. Report on only one basic financial statement 
and there are no scope limitations?
[SAS 58, pars. 47-48 (AU 508.47 -.48)]
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N/A
Yes
b. Report on comparative statements of income, 
retained earnings and cash flows without 
presentation of the comparative balance 
sheets for the prior year ends?
[SAS 58, par. 8, fn. 7 (AU 508.08, fn. 7)] _____
c. Part of the audit was made by other 
independent auditors, and the principal 
auditor is indicating a division of 
responsibility for the audit in his report?
[SAS 1, sec. 543 (AU 543); SAS 58,
pars. 12-13 (AU 508.12-.13)] _____
d. Departure from a promulgated accounting 
principle when conformity would result in a 
misleading presentation?
[SAS 58, pars. 14-15 (AU 508.14 -.15)] _____
e. The report of a predecessor auditor for 
a prior year has not been included with 
current comparative financial statements?
[SAS 7 (AU 315); SAS 58, par. 83
(AU 508.83)] _____
f. Updating of a previously issued report? [SAS 
58, par. 78 (AU 508.78)]
g. Comparative financial statements with 
differing opinions?
[SAS 58, pars. 74-76 (AU 508.74 -.76)]
h. Audited and unaudited financial statements 
in comparative form?
[SAS 26, pars. 14-17 (AU 504.14-.17)]
i. Decision to emphasize a matter?
[SAS 58, par. 37 (AU 508.37)]
5. Has explanatory language been added to the 
standard auditor’s report if:
a. The financial statements are affected by
uncertainties concerning future events, the 
outcome of which is not susceptible of 
reasonable estimation at the date of the 
auditor’s report?
[SAS 58, pars. 16-33 (AU 508.16-.33)]
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No N/A
Yes No N/A
b. There is a substantial doubt about the 
entity’s ability to continue as a going 
concern?
[SAS 59, par. 12 (AU 341.12)]
c. There has been a material change between 
periods in accounting principles or in the 
method of their application?
[SAS 58, pars. 34-36 (AU 508.34 -.36)]
d. In an updated report on comparative 
financial statements, the opinion on a 
prior period is different from the one 
previously expressed?
[SAS 58, pars. 77-78 and 81-83 
(AU 508.77-.78 and .81-.83)]
e. Selected quarterly financial data required 
by SEC Regulation S-K has been omitted or 
has not been reviewed?
[SAS 36 (AU 722)]
f. Supplementary information required by the 
Financial Accounting Standards Board (FASB) 
or the Governmental Accounting Standards 
Board (GASB) has been omitted, or the 
presentation of such information departs 
materially from FASB or GASB guidelines,
or the auditor is unable to complete 
prescribed procedures with respect to such 
information or remove substantial doubts 
about whether the supplementary information 
conforms to FASB or GASB guidelines?
[SAS 52, par. 2]
g. Other information in a document containing 
audited financial statements is materially 
inconsistent with information appearing in 
the financial statements?
[SAS 8 (AU 550)]
h. A matter regarding the financial statements 
needs to be emphasized?
[SAS 58, par. 37 (AU 508.37)]
6. Has a qualified opinion or disclaimer of
opinion been expressed if scope limitations 
precluded application of one or more auditing
43
Yes
procedures considered necessary in the 
circumstances?
[SAS 58, pars. 40-45 (AU 508.40-.45);
SAS 31, par. 23 (AU 326.23)] _____
7. Has a qualified or adverse opinion been 
expressed if a lack of conformity with 
generally accepted accounting principles 
(including inadequate disclosure) is present?
[SAS 32, par. 3 (AU 431.03); SAS 34, par. 11 
(AU 340.11)? SAS 58, pars. 49-66
(AU 508.49-.66); SAS 54, par. 18 (AU 317.18)] _____
8. If a qualified opinion, adverse opinion or 
disclaimer of opinion is expressed:
a. Are all the substantive reasons for the 
opinion or disclaimer disclosed?
[SAS 58, pars. 39, 68 and 71
(AU 508.39, .68 and .71)] _____
b. Is the reporting language clear and 
appropriate?
[SAS 58, pars. 38-72 (AU 508.38 -.72)] _____
9. Does the report include modification, if 
applicable, for the following:
a. Conditions that precluded application of 
necessary auditing procedures to opening 
inventories and/or long-term investments?
[SAS 58, par. 42 (AU 508.42)] _____
b. Regulated companies?
[SAS 1, sec. 544.02 -.04 (AU 544.02 -.04);
SAS 62, pars. 2-10 (AU 623.02-.10)] _____
c. Client representations about related party 
transactions?
[SAS 45, par. 12 (AU 334.12)] _____
d. Client’s refusal to provide written 
representation?
[SAS 19, par. 11 (AU 333.11)] _____
e. Limitations on scope of lawyer’s response? 
[SAS 12, pars. 12-14 (AU 337.12-.14)]
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No N/A
Yes No N/A
f. Unresolved matters involving specialists? 
[SAS 11, par. 9 (AU 336.09)]
g. Financial statements materially affected by 
an irregularity?
[SAS 53, par. 26 (Au 316. 26)]
h. Illegal acts by clients?
[SAS 54 (AU 317)]
i. [Reserved]
j. Segment information?
[SAS 21 (AU 435)]
k. Material misstatement of the financial 
statements?
[SAS 47, par. 31 (AU 312.31)]
l. Financial statements issued before the 
effective date of a Statement of 
Governmental Accounting and Financial 
Reporting Standards (GAFRS) or Statement of 
Financial Accounting Standards (SFAS) when 
disclosure is not made of the effect of a 
restatement which will be required in the 
future as a result of the GASB or FASB 
Statement?
[Interpretation 3 of SAS 1, section 410 (AU 
9410.13-.19)]
10. Has a piecemeal opinion been avoided?
[SAS 62, par. 14 (AU 623.14); SAS 58, 
par. 73 (AU 508.73)]
11. For the following special reports, have the 
applicable requirements been complied with:
a. Statements prepared in accordance with a 
comprehensive basis of accounting other than 
generally accepted accounting principles? 
[SAS 62, pars. 2-10 (AU 623.02-.10)]
b. Specified elements, accounts or items of a 
financial statement?
[SAS 62, pars. 11-18 (AU 623.11-.18);
SAS 35 (AU 622)]
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c. Compliance with aspects of agreements or 
regulatory requirements relating to audited 
financial statements?
[SAS 62, pars. 19-26 (AU 623.19 -.26)]
d. Financial information that requires a 
prescribed form of auditor’s report?
[SAS 62, pars. 32-33 (AU 623.32 -.33)]
12. If information is to accompany the basic 
financial statements and auditor’s report in 
an auditor-submitted document:
a. Is there a clear distinction between the 
client's representations and auditor’s 
representations?
[SAS 29, par. 20 (AU 551.20)]
b. Does the auditor's report on the 
accompanying information:
(1).  State that the audit was made for the
purpose of forming an opinion on the basic 
financial statements taken as a whole?
(2).  Specifically identify the accompanying
information?
(3).  State that the accompanying information is
presented for purposes of analysis and is 
not part of the basic financial 
statements?
(4).  State whether the additional information
has been subjected to the auditing 
procedures applied in auditing the basic 
financial statements and the appropriate 
expression or disclaimer?
[SAS 29, pars. 6-11 (AU 551.06 -.11)]
13. If an auditor-submitted document with 
accompanying information (long-form report) is 
co-existing with a document that includes just 
the basic financial statements and auditor's 
report:
a. Do the basic financial statements in all 
co-existing documents consistently include
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all the information necessary for a fair 
presentation in conformity with generally 
accepted accounting principles?
[SAS 29, par. 21 (AU 551.21)]
b. Are any additional comments or
explanations by the auditor consistent 
with the description of the scope of the 
audit in the auditor’s report?
[SAS 29, par. 20 (AU 551.20)]
14. If the document contains interim financial 
information, has the auditor’s report been 
expanded if required?
[SAS 36, pars. 24-30 (AU 722.24 -.30)]
15. If supplementary information required by the 
FASB is presented outside the basic financial 
statements in an auditor-submitted document, 
has an opinion been disclaimed on such 
information unless it has been audited?
[SAS 29, par. 7 (AU 551.07); SAS 27, pars. 8 
and 11 (AU 553.08 and .11)]
16. Significant deficiencies in the internal 
control structure that could adversely affect 
financial reporting must be reported, 
preferably in writing, to the audit committee 
or to individuals with equivalent
responsibility and authority [SAS 60, pars.
1-2 (AU 325.01 -.02)]. If a report on 
internal accounting control is to be issued, 
is the appropriate form used for:
a. Expression of an opinion on the entity’s 
system of internal accounting control in 
effect as of a specified date or during a 
specific period of time?
[SAS 30, pars. 37-46 (AU 642.37 -.46)]
b. Reporting on significant deficiencies or 
other appropriate matters regarding the 
internal control structure that were noted 
during an audit?
[SAS 60 (AU 325)]
c. Reports for restricted use of management and 
specified regulatory agencies, based on the
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regulatory agencies’ pre-established 
criteria?
[SAS 30, pars. 54-59 (AU 642.54 -.59)]
d. Other special purpose reports on all or part 
of an existing or proposed system for 
restricted use of management or specified 
third parties?
[SAS 30, pars. 60-61 (AU 642.60 -.61)]
17. If reporting in a client-prepared document on 
condensed financial statements (either for an 
annual or an interim period) that are derived 
from audited financial statements of a public 
entity that is required to file, at least 
annually, complete audited financial 
statements with a regulatory agency, does the 
auditor’s report indicate:
a. That the auditor has audited and expressed 
an opinion on the complete financial 
statements?
b. The date of the report on the complete 
financial statements?
c. The type of opinion expressed?
d. Whether, in the auditor’s opinion, the 
information set forth in the condensed 
financial statements is fairly stated in 
all material respects in relation to the 
complete financial statements from which 
it has been derived?
[SAS 42, pars. 5-6 and SAS 58, par. 8 
(AU 552.05-.06)]
18. If a statement that names the auditor, and 
states that condensed financial statements 
have been derived from audited financial 
statements, is made in a client-prepared 
document that does not include audited 
financial statements, and the client is not a 
public entity that is required to file 
complete audited financial statements with a 
regulatory agency at least annually, does the 
auditor’s report express an adverse opinion on 
the condensed financial statements because of
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inadequate disclosure?
[SAS 42, par. 7, fn. 6 (AU 552.07, fn. 6)]
19. If reporting on selected financial data that 
are included in a client-prepared document 
that contains audited financial statements 
(or, with respect to a public entity, that 
incorporates such statements by reference to 
information filed with a regulatory agency) 
and that are derived from audited financial 
statements, does the auditor’s report indicate 
the following:
a. That the auditor has audited and expressed 
an opinion on the complete financial 
statements?
b. The type of opinion expressed?
c. The specific data reported on?
d. Whether, in the auditor’s opinion, the 
information set forth in the selected 
financial data is fairly stated in all 
material respects in relation to the 
complete financial statements from which 
it has been derived?
20. If the selected financial data for any of the 
years presented are derived from financial 
statements that were audited by another 
independent auditor, does the auditor’s report 
on the selected financial data state that fact 
and express a disclaimer of opinion on that 
data?
[SAS 42, par. 9 (AU 552.09)]
21. If a U.S.-style report is modified to report
on financial statements prepared in conformity 
with accounting principles generally accepted 
in another country that are intended for use 
only outside the United States, does the 
auditor’s report:
a. Identify the financial statements audited? _____
b. Refer to the note to the financial 
statements that describes the basis of
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presentation of the financial statements on 
which the auditor is reporting, including 
identification of the nationality of the 
accounting principles?
c. State that the audit was made in accordance 
with auditing standards generally accepted 
in the United States (and, if appropriate, 
with the auditing standards of the other 
country)?
d. Include a paragraph that expresses or 
disclaims an opinion on the following:
(1).  Whether the financial statements are
presented in conformity with the basis of 
accounting described? (If the auditor 
concludes that the financial statements 
are not presented fairly on the basis of 
accounting described, all of the 
substantive reasons for that conclusion 
should be disclosed in one or more 
additional explanatory paragraphs of the 
report, and the opinion paragraph should 
include appropriate modifying language as 
well as a reference to the explanatory 
paragraphs.)
(2).  Whether the disclosed basis of accounting
used has been applied in a consistent 
manner?
[SAS 51, par. 9 (AU 534.09)]
22. If an independent auditor uses the auditor’s 
standard report of another country when 
reporting on financial statements prepared for 
use in that country:
a. Would such a report be used by auditors in 
that country in similar circumstances?
b. Does the auditor understand, and is he 
in a position to make, the attestations 
contained in such a report based on his 
knowledge of applicable legal
responsibilities, in addition to the 
auditing standards and the accounting 
principles generally accepted in that 
country?
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c. Has the auditor considered consulting with 
persons having expertise in the audit 
reporting practices of that country to 
attain the understanding needed to issue 
that country’s standard report?
[SAS 51, pars. 11-12 (AU 534.11 -.12)]
23. If a U.S. entity has prepared financial 
statements in conformity with U.S. generally 
accepted accounting principles (GAAP) and 
accounting principles generally accepted in 
another country (OCAP), has the auditor 
considered including, in one or both reports, 
a statement that another report has been 
issued on the financial statements for the 
entity that have been prepared in accordance 
with OCAP, with reference to any notes 
describing significant differences between 
the accounting principles used and U.S. GAAP? 
[SAS 51, par. 13 (AU 534.13)]
24. If reporting on the fair presentation of 
financial statements prepared in conformity 
with OCAP that will have more than limited 
distribution in the United States, has the 
auditor:
a. Used the U.S. standard form of report 
[SAS 58, par. 8] modified as appropriate 
[SAS 58, pars. 49-66] because of departures 
from U.S. GAAP? (This does not apply to 
reports on financial statements of U.S. 
subsidiaries of foreign registrants 
presented in SEC filings of foreign parent 
companies where the subsidiaries’ financial 
statements have been prepared on the basis 
of accounting principles used by the parent 
company.)
[SAS 51, par. 14, fn. 2 (AU 534.14, 
fn. 2)]
b. Expressed an opinion, in a separate 
paragraph, on whether the financial 
statements are presented in conformity with 
OCAP?
[SAS 51, par. 14 (AU 534.14)]
25. If reporting on the same set of financial
51
Yes No N/A
statements prepared in conformity with 
OCAP that will have more than limited 
distribution in the United States, has the 
guidance in No. 21 above been followed for 
distribution outside the United States and 
No. 24 above for distribution in the United 
States?
[SAS 51, par. 15 (AU 534.15)]
B. COMPILATION AND REVIEW REPORTS
1. Is the report appropriately worded as follows:
a. For compiled financial statements does the 
report state that:
(1). A compilation has been performed in
accordance with standards established by 
the American Institute of Certified Public 
Accountants?
(2).  A compilation is limited to presenting in
the form of financial statements 
information that is the representation of 
management (owners)?
[See SSARS 3, par. 3 (AR 300.03) for 
different wording that may be used when 
the financial statements are included in a 
prescribed form and the form or related 
instructions call for departures from 
generally accepted accounting principles.] _____
(3).  The financial statements have not been
audited or reviewed and, accordingly, the 
accountant does not express an opinion or 
any other form of assurance on them?
[SSARS 1, par. 14 (AR 100.14); SSARS 5,
par. 1 (AR 500.01)] _____
b. For reviewed financial statements, does the 
report state that:
(1).  A review was performed in accordance with
standards established by the American 
Institute of Certified Public Accountants? _____
(2).  All information included in the financial
statements is the representation of the 
management (owners) of the entity? _____
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(3).  A review consists principally of inquiries
of company personnel and analytical
procedures applied to financial data? _____
(4).  A review is substantially less in scope
than an audit, the objective of which is 
the expression of an opinion regarding the 
financial statements taken as a whole and, 
accordingly, no such opinion is expressed? _____
(5).  The accountant is not aware of any
material modifications that should be made 
to the financial statements in order for 
them to be in conformity with generally 
accepted accounting principles or, where 
applicable, with another comprehensive 
basis of accounting, other than those 
modifications, if any, indicated in his 
report?
[SSARS 1, par. 32 (AR 100.32)] _____
c. For both compiled and reviewed financial 
statements, does the report exclude a 
description of any other procedures that the 
accountant might have performed before or 
during the engagement?
[SSARS 1, pars. 14 and 32 (AR 100.14 and 
.32)]
2. For compiled financial statements that 
contain departures (unless required by a 
prescribed form or related instructions when 
the accountant issues a SSARS 3 [AR 300] 
compilation report on financial statements 
included in a prescribed form) from generally 
accepted accounting principles or, where 
applicable, another comprehensive basis of 
accounting:
a. If the departure is the omission in 
compiled financial statements of 
substantially all required disclosures, 
does the accountant's report clearly 
indicate such omission?
[SSARS 1, pars. 19 and 21 (AR 100.19 
and .21)]
b. If compiled financial statements that omit
53
Yes No N/A
substantially all of the disclosures 
required by generally accepted accounting 
principles include disclosures about only a 
few matters in the form of notes to such 
financial statements, are such disclosures 
labeled "Selected Information -
Substantially All Disclosures Required by 
Generally Accepted Accounting Principles 
(or, where applicable, another comprehensive 
basis of accounting) Are Not Included"?
[SSARS 1, par. 19 (AR 100.19)] _____
c. If compiled financial statements that omit 
substantially all required disclosures are 
prepared on a basis of accounting other than 
generally accepted accounting principles, 
and if such financial statements do not 
include disclosure of the basis of 
accounting used, does the accountant’s 
report disclose the basis of accounting?
[SSARS 1, par. 20 (AR 100.20)] _____
d. If compiled financial statements contain 
another departure from generally accepted 
accounting principles or, where applicable, 
another comprehensive basis of accounting, 
did the accountant modify his report to 
disclose the departure?
[SSARS 1, par. 39 (AR 100.39)] _____
(1).  If yes, did the accountant's modified
report disclose the departure in a
separate paragraph? _____
(2).  If the effects of the departure on the
financial statements have been determined 
by management or are known as a result of 
the accountant’s procedures, are these 
effects disclosed in the modified report? _____
(3).  If the effects of the departure on the
financial statements have not been 
determined, has the accountant stated this 
in his report?
[SSARS 1, par. 40 (AR 100.40)] _____
3. For reviewed financial statements that contain 
departures from generally accepted accounting
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principles or, where applicable, another 
comprehensive basis of accounting (including 
the omission of required disclosures), did the 
accountant modify his report to disclose the 
departure?
[SSARS 1, par. 39 (AR 100.39)] _____
a. If yes, did the accountant’s modified report
disclose the departure in a separate 
paragraph? _____
b. If the effects of the departure on the 
financial statements have been determined 
by management or are known as a result of 
the accountant's procedures, are these
effects disclosed in the modified report? _____
c. If the effects of the departure on the 
financial statements have not been 
determined, has the accountant stated this 
in his report?
[SSARS 1, par. 40 (AR 100.40)] _____
4. If the accountant is not independent with 
respect to the entity for which he has 
compiled financial statements, did the 
accountant state in the last paragraph of his 
report "I am (we are) not independent with 
respect to XYZ Company"? (The accountant is 
precluded from issuing a review report on the 
financial statements of an entity with respect 
to which he is not independent.)
[SSARS 1, pars. 22 and 38 (AR 100.22
and .38)] _____
5. Is the report dated? _____
6. Does each page of the financial statements:
a. If compiled by the accountant, include a 
reference such as "See Accountant's 
Compilation Report"?
[SSARS 1, par. 16 (AR 100.16)]
b. If reviewed by the accountant, include a 
reference such as "See Accountant's Review 
Report"?
[SSARS 1, par. 34 (AR 100.34)] _____
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7. When accompanying information is presented 
with the financial statements, did the 
accountant clearly indicate his degree of 
responsibility with respect to such 
information as follows:
a. If the basic financial statements were
reviewed, was the degree of responsibility 
disclosed in the report or in a separate 
report on the other data that states:
(1).  The review has been made primarily for the
purpose of expressing limited assurance 
that there are no material modifications 
that should be made to the financial 
statements in order for them to be in 
conformity with generally accepted 
accounting principles or, where
applicable, another comprehensive basis of 
accounting?
(2).  The other data accompanying the financial
statements are presented only for 
supplementary analysis purposes and:
(a). Have been subjected to the inquiry and
analytical procedures applied in the 
review of the basic financial 
statements, and the accountant did not 
become aware of any material 
modifications that should be made to 
such data, or
(b). Have not been subjected to the inquiry
and analytical procedures applied in the 
review of the basic financial 
statements, but were compiled from 
information that is the representation 
of management, without audit or review, 
and the accountant does not express an 
opinion or any other form of assurance 
on such data?
b. If the accountant has compiled both the 
basic financial statements and other data 
which are presented for supplementary 
analysis purposes, does the compilation 
report also include the other data?
[SSARS 1, par. 43 (AR 100.43)]
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8. If an audit engagement has been changed to a 
review or compilation, does the report omit 
reference to: a) the original engagement, b) 
any auditing procedures that may have been 
performed, and c) any scope limitation that 
resulted in the changed engagement?
[SSARS 1, par. 49 (AR 100.49)]
9. If comparative financial statements are 
presented, does the accountant’s report cover 
each period presented?
[SSARS 2, par. 2 (AR 200.02)]
10. Is the report appropriate for the current 
status of the entity?
[SSARS 2, pars. 31-32 (AR 200.31 -.32)]
11. Does each page of the comparative financial 
statements compiled or reviewed include a 
reference such as "See Accountant’s Report"? 
[SAARS 2, par. 6 (AR 200.06)]
12. If compiled financial statements which omit 
substantially all of the disclosures required 
by generally accepted accounting principles 
are included among the comparative financial 
statements, do all the periods presented also 
omit such disclosures and does the
accountant’s compilation report include an 
additional paragraph which indicates:
a. The nature of the previous service rendered 
(compilation, review or audit)?
b. Date of the previous report?
c. Appropriate language in accordance with 
SSARS 1, pars. 19-20 and SSARS 2, par. 30? 
[SSARS 1, pars. 19-21 (AR 100.19-.21);
SSARS 2, pars. 5, 29, and 30 (AR 200.05 
and .29-.30)]
13. If the level of service performed by the 
continuing accountant on the current-period 
financial statements is the same or higher 
than that performed on the financial 
statements of the prior period presented, has 
the continuing accountant's report on the
57
No N/A
Yes No N/A
prior period been updated?
[SSARS 2, pars. 8-10 (AR 200.08 -.10)]
14. If the level of service performed by the 
continuing accountant on the current-period 
financial statements is lower than that 
performed on the financial statements of the 
prior period presented:
a. Does the report on the current period 
include a separate paragraph which describes 
the responsibility assumed for the prior 
period?
b. If not, is the report on the current period 
accompanied by or combined with a reissued 
report on the financial statements of the 
prior period presented?
[SSARS 2, pars. 8, 11 and 12 (AR 200.08 and 
.11-.12)]
15. If the report requires a changed reference to 
a departure from generally accepted accounting 
principles regarding the prior period 
presented, does the explanatory paragraph in 
the report include:
a. The date of the previous report?
b. Description of the circumstances or events 
underlying the change?
c. Indication, if applicable, that the 
prior-period financial statements have 
changed?
[SSARS 2, pars. 14-15 (AR 200.14 -.15)]
16. If the predecessor accountant does not 
reissue his compilation or review report 
on prior-period financial statements, has 
the successor either made appropriate 
reference in his report to the predecessor’s 
report in accordance with SSARS 2, or 
performed a compilation, review, or audit
of the statements of the prior period and 
reported on them accordingly?
[SSARS 2, pars. 16-19 (AR 200.16 -.19)]
58
Yes No N/A
17. If the financial statements of the prior 
period presented have been changed, has the 
predecessor or successor accountant reported 
on them as presented?
[SSARS 2, pars. 25-26 (AR 200.25 -.26)]
18. If the current-period financial statements 
were compiled or reviewed, and the financial 
statements of the prior period presented were 
audited, and the audit report has not been 
reissued, does the current-period report 
include a separate paragraph which contains 
the following:
a. Statement that the prior-period financial 
statements were audited previously?
b. Date of the previous report?
c. Type of opinion expressed previously?
d. If the opinion was other than unqualified, 
the substantive reasons therefor?
e. That no auditing procedures were performed 
after the date of the previous report?
(For guidance on situations when the 
current period is audited and the prior 
period is compiled or reviewed, see
SAS 26 [AU 504].)
[SSARS 2, par. 28 (AR 200.28)]
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SAMPLE HOSPITAL
Statements of Revenue and Expenses of General Funds
Years Ended December 31, 19X7 and 19X6
See accompanying notes to financial statements.
19X7 19X6
Net patient service revenue (notes 3, 7 and 15) $92,656,000 $88,942,000
Other revenue 6,010,000 5,380,000
Total revenue 98,666,000 94,322,000
Expenses (notes 7, 8, 12, and 13)
Professional care of patients 53,016,000 48,342,000
Dietary services 4,407,000 4,087,000
General services 10,888,000 9,973,000
Administrative services 11,075,000 10,145,000
Employee health and welfare 10,000,000 9,335,000
Medical malpractice costs 1,125,000 200,000
Depreciation and amortization of property and equipment 4,782,000 4,280,000
Interest 1,752,000 1,825,000
Provision for bad debts 1,010,000 1,103,000
Total expenses 98,055,000 89,290,000
Income from operations 611,000 5,032,000
Nonoperating gains (losses)
Unrestricted gifts and bequests (note 10) 822,000 926,000
Loss on investment in affiliated company (note 4) (37,000) (16,000)
Income on investments of endowment funds 750,000 650,000
Income on investments whose use is limited
By board for capital improvements 1,120,000 1,050,000
By agreements with third-party payors for funded depreciation 850,000 675,000
Under indenture agreement 100,000 90,000
Other investment income 284,000 226,000
Nonoperating gains, net 3,889,000 3,601,000
Revenue and gains in excess of expenses and losses $ 4,500,000 $ 8,633,000
66
SA
M
PL
E 
HO
SP
IT
AL
St
at
em
en
ts
 o
f C
ha
ng
es
 in
 Fu
nd
 B
al
an
ce
s
Ye
ar
s E
nd
ed
 D
ec
em
be
r 3
1,
 19
X7
 a
nd
 19
X6
__
__
__
__
__
__
__
__
__
__
__
_1
9X
7_
__
__
__
__
__
__
__
__
__
__
__
 _____
__
__
__
__
__
__
__
__
__
19
X6
__
__
__
__
__
__
__
__
__
__
__
_
D
on
or
-R
es
tri
ct
ed
 F
un
ds
 
D
on
or
-R
es
tri
ct
ed
 F
un
ds
En
do
w
m
en
t
Fu
nd
s
$5
,9
73
,0
00
10
0,
00
0
10
0,
00
0
$6
,0
73
,0
00
Pl
an
t
Re
pl
ac
em
en
t 
an
d 
Ex
pa
n­
sio
n 
Fu
nd
s
$5
01
,0
00
29
0,
00
0
15
,0
00
20
,0
00
(2
55
,0
00
)
70
,0
00
50
,0
00
50
,0
00
$5
21
,0
00
Sp
ec
ifi
c-
Pu
rp
os
e
Fu
nd
s
$ 933
,0
00
55
8,
00
0
50
,0
00
60
8,
00
0
50
0,
00
0
50
0,
00
0
$1
,0
41
,0
00
En
do
w
m
en
t 
G
en
er
al
Fu
nd
s 
Fu
nd
s
$6
,0
73
,0
00
 
$5
6,
67
9,
00
0
- 
8,
63
3,
00
0
- 
25
5,
00
0
- 
8,
88
8,
00
0
- 
1,
00
0,
00
0
63
9,
00
0 
-
17
5,
00
0 
-
81
4,
00
0 
1,
00
0,
00
0
$5
,2
59
,0
00
 
$6
4,
56
7,
00
0
Pl
an
t
Re
pl
ac
em
en
t 
an
d 
Ex
pa
n­
sio
n 
Fu
nd
s
$5
21
,0
00
22
0,
00
0
20
,0
00
10
0,
00
0
(2
43
,0
00
)
97
,0
00
60
,0
00
60
,0
00
$5
58
,0
00
Sp
ec
ifi
c-
Pu
rp
os
e
Fu
nd
s
$1
,0
41
,0
00
86
9,
00
0
62
,0
00
93
1,
00
0
55
0,
00
0
55
0,
00
0
$1
,4
22
,0
00
G
en
er
al
Fu
nd
s
$6
4,
56
7,
00
0
4,
50
0,
00
0
24
3,
00
0
4,
74
3,
00
0
$6
9,
31
0,
00
0
Se
e a
cc
om
pa
ny
in
g 
no
te
s t
o f
in
an
ci
al
 st
at
em
en
ts
.
Ba
la
nc
es
 at
 b
eg
in
ni
ng
 o
f y
ea
r 
A
dd
iti
on
s
Re
ve
nu
e a
nd
 g
ai
ns
 in
 ex
ce
ss
 of
 
ex
pe
ns
es
 an
d 
lo
ss
es
G
ift
s, g
ra
nt
s, a
nd
 b
eq
ue
st
s
(n
ot
es
 10
 an
d 1
1)
In
ve
st
m
en
t i
nc
om
e
N
et
 re
al
iz
ed
 g
ai
n 
on
 sa
le
 o
f i
nv
es
tm
en
ts
 
Tr
an
sf
er
 to
 fi
na
nc
e p
ro
pe
rty
 an
d
eq
ui
pm
en
t a
dd
iti
on
s
D
ed
uc
tio
ns
Pr
ov
isi
on
 fo
r u
nc
ol
le
ct
ib
le
 p
le
dg
es
 
Ca
pi
ta
l c
on
tri
bu
tio
n 
to
 Sa
m
pl
e
H
ea
lth
 Sy
st
em
 (n
ot
e 1
1)
N
et
 re
al
iz
ed
 lo
ss
 o
n 
sa
le
 o
f i
nv
es
tm
en
ts
 
U
nr
ea
liz
ed
 lo
ss
 on
 m
ar
ke
ta
bl
e e
qu
ity
se
cu
rit
ie
s (
no
te
 9)
Tr
an
sf
er
 to
 ot
he
r r
ev
en
ue
Ba
la
nc
es
 at
 en
d 
of
 y
ea
r
67
SAMPLE HOSPITAL
Statements of Cash Flows of General Funds (Direct Method)*
Years Ended December 31, 19X7 and 19X6
See accompanying notes to financial statements.
19X7 19X6
Cash flows from operating activities and gains and losses
Cash received from patients and third-party payors $ 90,342,000 $ 85,619,000
Cash paid to employees and suppliers (89,214,000) (81,510,000)
Other receipts from operations 6,042,000 5,563,000
Receipts from unrestricted gifts and bequests 1,122,000 905,000
Interest and dividends received 2,510,000 2,330,000
Interest paid (net of amount capitalized) (1,780,000) (1,856,000)
Net cash provided by operating activities and gains and losses 9,022,000 11,051,000
Cash flows from investing activities
Purchase of property and equipment (4,728,000) (5,012,000)
Transfer from donor-restricted fund for purchase of property
and equipment 243,000 255,000
Investment in affiliated company (394,000) (425,000)
Transfer to Sample Health System — (1,000,000)
Cash invested in assets whose use is limited (4,798,000) (855,000)
Net cash used by investing activities (9,677,000) (7,037,000)
Cash flows from financing activities
Increase in retainage and construction accounts payable 183,000 175,000
Repayment of long-term debt (1,200,000) (1,630,000)
Payments from donor-restricted funds related to temporary loans 500,000 —
Payments on capital lease obligations (550,000) (600,000)
Temporary loans from (to) donor-restricted funds 300,000 (193,000)
Net cash used by financing activities (767,000) (2,248,000)
Net increase (decrease) in cash and cash equivalents (1,422,000) 1,766,000
Cash and cash equivalents at beginning of year 4,525,000 2,759,000
Cash and cash equivalents at end of year $ 3,103,000 $ 4,525,000
* The direct and indirect methods of reporting cash flows by hospitals are presented for illustrative purposes. 
The indirect method is presented on page 70.
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Reconciliation of Revenue and Gains in Excess of Expenses and Losses 
to Net Cash Provided by Operating Activities and Gains and Losses
Revenue and gains in excess of expenses and losses
Adjustments to reconcile revenue and gains in excess of expenses 
and losses to net cash provided by operating activities and gains and losses
$4,500,000 $ 8,633,000
Depreciation and amortization of property and equipment 4,782,000 4,280,000
Provision for bad debts 1,010,000 1,103,000
Amortization of deferred financing costs 66,000 45,000
Loss on investment in affiliated company 53,000 —
Noncash gifts and bequests — (175,000)
Decrease in amounts due to third-party payors (398,000) (77,000)
Increase in liability for estimated malpractice costs 1,125,000 200,000
Increase in patient accounts receivable (1,916,000) (3,141,000)
Increase in supplies and other current assets (193,000) (118,000)
Increase in accounts payable and accrued expenses 303,000 301,000
Increase in interest earned but not received on assets whose use is limited (310,000) —
Net cash provided by operating activities and gains and losses $ 9,022,000 $11,051,000
Supplemental Disclosures of Cash Flow Information
Sample Hospital entered into capital lease obligations of $600,000 for new equipment in 19X7.
See accompanying notes to financial statements.
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SAMPLE HOSPITAL
Statements of Cash Flows of General Funds (Indirect Method)*
Years Ended December 31, 19X7 and 19X6
19X7 19X6
Cash flows from operating activities and gains and losses
Revenue and gains in excess of expenses and losses $ 4,500,000 $ 8,633,000
Adjustments to reconcile revenue and gains in excess of expenses and 
losses to net cash provided by operating activities and gains and losses
Depreciation and amortization of property and equipment 4,782,000 4,280,000
Provision for bad debts 1,010,000 1,103,000
Amortization of deferred financing costs 66,000 45,000
Loss on investment in affiliated company 53,000 —
Noncash gifts and bequests — (175,000)
Decrease in net amounts due to third-party payors (398,000) (77,000)
Increase in liability for estimated malpractice costs 1,125,000 200,000
Increase in patient accounts receivable (1,916,000) (3,141,000)
Increase in supplies and other current assets (193,000) (118,000)
Increase in accounts payable and accrued expenses 303,000 301,000
Increase in interest earned but not received on assets whose use is limited (310,000) —
Net cash provided by operating activities and gains and losses 9,022,000 11,051,000
Cash flows from investing activities
Purchase of property and equipment (4,728,000) (5,012,000)
Transfer from donor-restricted fund for purchase of property
and equipment 243,000 255,000
Investment in affiliated company (394,000) (425,000)
Transfer to Sample Health System — (1,000,000)
Cash invested in assets whose use is limited (4,798,000) (855,000)
Net cash used by investing activities (9,677,000) (7,037,000)
Cash flows from financing activities
Increase in retainage and construction accounts payable 183,000 175,000
Repayment of long-term debt (1,200,000) (1,630,000)
Payments from donor-restricted funds related to temporary loans 500,000 —
Payments on capital lease obligation (550,000) (600,000)
Temporary loans from (to) donor-restricted funds 300,000 (193,000)
Net cash used by financing activities (767,000) (2,248,000)
Net increase (decrease) in cash and cash equivalents (1,422,000) 1,766,000
Cash and cash equivalents at beginning of year 4,525,000 2,759,000
Cash and cash equivalents at end of year $ 3,103,000 $ 4,525,000
Supplemental Disclosures of Cash Flow Information
Sample Hospital entered into capital lease obligations of $600,000 for new equipment in 19X7.
Cash paid for interest (net of amount capitalized) in 19X7 and 19X6 was $1,780,000 and $1,856,000, respectively. 
See accompanying notes to financial statements.
* The direct and indirect methods of reporting cash flows by hospitals are presented for illustrative purposes. 
The direct method is presented on pages 68 and 69.
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SAMPLE HOSPITAL
Notes to Financial Statements
December 31, 19X7 and 19X6
1. Summary of Significant Accounting Policies
Organization
Sample Hospital (Hospital) is a not-for-profit acute care hospital. Effective June 30, 19X6, under a plan of reorganiza­
tion, Sample Health System was formed as the parent holding company of the Hospital. In its capacity as sole 
member of the Hospital, Sample Health System has the right to appoint Hospital trustees, approve major Hospital 
expenditures, and approve long-term Hospital borrowings.
Charity care
The Hospital provides care to patients who meet certain criteria under its charity care policy without charge or at 
amounts less than its established rates. Because the Hospital does not pursue collection of amounts determined to 
qualify as charity care, they are not reported as revenue.
Income taxes
The Hospital is a not-for-profit corporation as described in Section 501(c)(3) of the Internal Revenue Code and is 
exempt from federal income taxes on related income pursuant to Section 501(a) of the Code.
Net patient service revenue
Net patient service revenue is reported at the estimated net realizable amounts from patients, third-party payors, 
and others for services rendered, including estimated retroactive adjustments under reimbursement agreements 
with third-party payors. Retroactive adjustments are accrued on an estimated basis in the period the related services 
are rendered and adjusted in future periods as final settlements are determined.
Investments and investment income
Donated investments are reported at fair value at the date of receipt, which is then treated as cost. Marketable equity 
securities included in investment portfolios are carried at the lower of aggregate cost (determined on an average-cost 
basis) or market at the balance sheet date. Other marketable securities are stated at cost, adjusted for impairments 
in value that are deemed to be other than temporary. Sample Hospital's investment in Affiliated Company is 
reported on the equity method of accounting that approximates Sample Hospital's equity in the underlying net 
assets of Affiliated Company.
Investment income on proceeds of borrowings that are held by a trustee, to the extent not capitalized, and invest­
ment income on assets deposited in the malpractice trust are reported as other revenue. Investment income from 
all other general fund investments and investment income of endowment funds are reported as nonoperating 
gains. Investment income and gains (losses) on investments of donor-restricted funds are added to (deducted from) 
the appropriate restricted fund balance.
Pledges
Pledges, less an allowance for uncollectible amounts, are recorded as receivables in the year made. Unrestricted 
pledges are reported in the statement of revenue and expenses of general funds; restricted pledges are reported as 
additions to the appropriate restricted fund balance.
Statement of revenue and expenses of general funds
For purposes of display, transactions deemed by management to be ongoing, major, or central to the provision of 
health care services are reported as revenues and expenses. Peripheral or incidental transactions are reported as 
gains and losses.
Costs of borrowing
Interest cost incurred on borrowed funds during the period of construction of capital assets is capitalized as a 
component of the cost of acquiring those assets.
Deferred financing costs are amortized over the period the obligation is outstanding using the interest method.
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Amortization of deferred financing costs is capitalized during the period of construction of capital assets.
Donor-restricted funds
Donor-restricted funds are used to differentiate resources, the use of which is restricted by donors or grantors, from 
resources of general funds on which donors or grantors place no restriction or that arise as a result of the operations 
of the Hospital for its stated purposes. Restricted gifts and other restricted resources are recorded as additions to 
the appropriate restricted fund.
Resources restricted by donors for plant replacement and expansion are added to the general fund balance to the 
extent expended within the period.
Resources restricted by donors or grantors for specific operating purposes are reported in other operating revenue 
to the extent used within the period.
Assets whose use is limited
Assets whose use is limited include assets set aside by the Board of Trustees for future capital improvements, over 
which the Board retains control and may at its discretion subsequently use for other purposes; assets set aside in 
accordance with agreements with third-party payors; and assets held by trustees under indenture agreements and 
self-insurance trust arrangements.
Property and equipment
Property and equipment acquisitions are recorded at cost. Property and equipment donated for hospital operations 
are recorded as additions to the donor-restricted plant replacement and expansion funds at fair value at the date of 
receipt and as transfers to the general fund balance when the assets are placed in service.
Depreciation is provided over the estimated useful life of each class of depreciable asset and is computed on the 
straight-line method. Equipment under capital leases is amortized on the straight-line method over the shorter 
period of the lease term or the estimated useful life of the equipment. Such amortization is included in depreciation 
and amortization in the financial statements.
An accelerated method for depreciating certain operating equipment acquired before 1970 has been elected for 
third-party reimbursement purposes. Third-party reimbursement is deferred to the extent of the effect of the differ­
ence between accelerated depreciation used for reimbursement reporting and straight-line depreciation used for 
financial reporting.
Cash and cash equivalents
Cash and cash equivalents include investments in highly liquid debt instruments with a maturity of three months 
or less, excluding amounts whose use is limited by board designation or other arrangements under trust agree­
ments or with third-party payors.
Estimated malpractice costs
The provision for estimated self-insured medical malpractice claims includes estimates of the ultimate costs for both 
reported claims and claims incurred but not reported.
2. Charity Care
The Hospital maintains records to identify and monitor the level of charity care it provides. These records include 
the amount of charges foregone for services and supplies furnished under its charity care policy, the estimated cost 
of those services and supplies, and equivalent service statistics. The following information measures the level of 
charity care provided during the years ended December 31, 19X7 and 19X6.
19X7 19X6
Charges foregone, based on established rates
Estimated costs and expenses incurred to provide charity care 
Equivalent percentage of charity care patients to all patients served
6,000,000 5,700,000
5,600,000 5,000,000
5.7% 5.6%
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3. Net Patient Service Revenue
The Hospital has agreements with third-party payors that provide for payments to the Hospital at amounts different 
from its established rates. A summary of the payment arrangements with major third-party payors follows.
• Medicare. Inpatient acute care services rendered to Medicare program beneficiaries are paid at prospectively 
determined rates per discharge. These rates vary according to a patient classification system that is based on 
clinical, diagnostic, and other factors. Inpatient nonacute services, certain outpatient services, and defined 
capital and medical education costs related to Medicare beneficiaries are paid based upon a cost reimburse­
ment methodology. The Hospital is reimbursed for cost reimbursable items at a tentative rate with final 
settlement determined after submission of annual cost reports by the Hospital and audits thereof by the 
Medicare fiscal intermediary. The Hospital's classification of patients under the Medicare program and the 
appropriateness of their admission are subject to an independent review by a peer review organization under 
contract with the Hospital. The Hospital's Medicare cost reports have been audited by the Medicare fiscal 
intermediary through December 31, 19X6.
• Medicaid. Inpatient and outpatient services rendered to Medicaid program beneficiaries are reimbursed 
under a cost reimbursement methodology. The Hospital is reimbursed at a tentative rate with final settlement 
determined after submission of annual cost reports by the Hospital and audits thereof by the Medicaid fiscal 
intermediary. The Hospital's Medicaid cost reports have been audited by the Medicaid fiscal intermediary 
through December 31, 19X6.
• Blue Cross. Inpatient services rendered to Blue Cross subscribers are reimbursed at prospectively deter­
mined rates per day of hospitalization. The prospectively determined per diem rates are not subject to 
retroactive adjustment.
The Hospital has also entered into payment agreements with certain commercial insurance carriers, health main­
tenance organizations, and preferred provider organizations. The basis for payment to the Hospital under these 
agreements includes prospectively determined rates per discharge, discounts from established charges, and 
prospectively determined daily rates.
4. Investment in Affiliated Company
In 19X2, the Hospital entered into an agreement with two unrelated hospitals to establish and operate an ambula­
tory care center, Affiliated Company (Center). In accordance with this agreement, each hospital invested $970,000 
for a 33⅓ percent equity interest in the common stock of the Center. The investment was made in installments 
during the years 19X5 through 19X7, and in May 19X7 the Center began operations. The investment is recorded on 
the equity method.
Summarized financial information from the unaudited financial statements of the Center follows.
Current assets 
Noncurrent assets 
Current liabilities 
Noncurrent liabilities 
Shareholders' equity
December 31, 19X7
$1,779,000
4,052,000
1,566,000
1,514,000
2,751,000
December 31, 19X6
$1,835,000
4,007,000
1,325,000
2,789,000
1,728,000
_______________Year Ended_______________
December 31, 19X7 December 31, 19X6
Revenue $3,220,000 $2,899,000
Net loss (111,000) (48,000)
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5. Assets Whose Use Is Limited
Assets whose use is limited that are required for obligations classified as current liabilities are reported in current 
assets. The composition of assets whose use is limited at December 31, 19X7 and 19X6, is set forth in the following 
table. Investments are stated at cost that approximates market.
19X7
By board for capital improvements
Cash and short-term investments $11,000,000
19X6
$10,000,000
By agreements with third-party payors for funded depreciation 
Cash and short-term investments $ 8,503,000
U.S. Treasury obligations 316,000
Interest receivable 415,000
$ 9,234,000
Under malpractice funding arrangement—held by trustee 
Cash and short-term investments $ 1,058,000
U.S. Treasury obligations 1,949,000
$ 3,007,000
Under indenture agreement—held by trustee
Cash and short-term investments $ 592,000
U.S. Treasury obligations 11,024,000
Interest receivable 92,000
$11,708,000
$ 5,712,000 
316,000 
123,000
$ 6,151,000
$ 857,000
1,825,000
$ 2,682,000
$ 1,260,000 
9,674,000 
74,000
$11,008,000
6. Property and Equipment
A summary of property and equipment at December 31, 19X7 and 19X6, follows.
19X7
Land $ 3,000,000
Land improvements 472,000
Buildings and improvements 46,852,000
Equipment 29,190,000
Equipment under capital leases 2,851,000
82,365,000
Less accumulated depreciation and amortization 34,928,000
47,437,000
Construction in progress 3,601,000
Property and equipment, net $51,038,000
19X6
$ 3,000,000 
472,000 
46,636,000 
26,260,000 
2,752,000
79,120,000
30,661,000
48,459,000
2,033,000
$50,492,000
Construction contracts of approximately $7,885,000 exist for the remodeling of Hospital facilities. At December 31, 
19X7, the remaining commitment on these contracts approximated $4,625,000.
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7. Long-Term Debt and Capital Leases
A summary of long-term debt and capital leases at December 31, 1987 and 19X6, follows.
19X7 19X6
9.25% Revenue Notes, due November 1, 19XX, collateralized by a pledge
of the Hospital's gross receipts $21,479,000 $22,016,000
9.25% mortgage loan, due January 19XX, collateralized by a mortgage 
on property and equipment with a depreciated cost of $1,800,000 at 
December 31, 19X7 2,010,000 2,127,000
9.75% note payable, due March 19XX, unsecured 125,000 671,000
Total long-term debt 23,614,000 24,814,000
Less current instalments of long-term debt 970,000 1,200,000
Long-term debt excluding current installments $22,644,000 $23,614,000
Capital lease obligations, at varying rates of imputed interest from 9.8% 
to 12.3%, on leased equipment with an amortized cost of $1,500,000 
at December 31, 19X7 $ 1,000,000 $ 950,000
Less current portion of capital lease obligations 500,000 550,000
Capital lease obligations, excluding current portion $ 500,000 $ 400,000
Under the terms of the Revenue Note Indenture, the Hospital is required to maintain certain deposits with a trustee. 
Such deposits are included with assets whose use is limited in the financial statements. The Revenue Note Inden­
ture also places limits on the incurrence of additional borrowings and requires that the Hospital satisfy certain 
measures of financial performance as long as the notes are outstanding.
Scheduled principal repayments on long-term debt and payments on capital lease obligations for the next five years 
are as follows:
Long-Term
Debt
Obligations 
Under Capital 
Leases
19X8 $ 970,000 $ 500,000
19X9 912,000 260,000
19Y0 983,000 260,000
19Y1 1,060,000 95,000
19Y2 1,143,000 —
$5,068,000 1,115,000
Less amount representing interest on
obligations under capital leases 115,000
$1,000,000
A summary of interest cost and investment income on borrowed funds held by the trustee under the Revenue Note
Indenture during 19X7 and 19X6 follows.
19X7 19X6
Interest cost
Capitalized
Charged to operations
$ 740,000 
1,752,000
$2,492,000
$ 740,000 
1,825,000
$2,565,000
Investment income
Capitalized
Credited to other revenue
$ 505,000 
330,000
$ 663,000 
386,000
$ 835,000 $1,049,000
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8. Medical Malpractice Claims
The Hospital is uninsured with respect to medical malpractice risks. Losses from asserted claims and from 
unasserted claims identified under the Hospital's incident reporting system are accrued based on estimates that 
incorporate the Hospital's past experience, as well as other considerations including the nature of each claim or 
incident and relevant trend factors. Accrued malpractice losses have been discounted at rates ranging from 7 percent 
to 9 percent. No accrual for possible losses attributable to incidents that may have occurred but that have not been 
identified under the incident reporting system has been made because the amount is not reasonably estimable. 
The Hospital has established an irrevocable trust fund for the payment of medical malpractice claim settlements. 
Professional insurance consultants have been retained to assist the Hospital with determining amounts to be 
deposited in the trust fund.
9. Endowment Funds—Investments
Donor-restricted endowment fund investment portfolios include marketable equity securities that are carried at 
the lower of cost or market. Marketable equity securities of endowment funds at December 31, 19X7 and 19X6, are 
summarized as follows:
Cost
Quoted
Market
Value
Gross
Unrealized
Gains
Gross
Unrealized
Losses
19X7 $1,476,000 $1,301,000 $ 8,000 $183,000
19X6 1,620,000 1,832,000 228,000 16,000
Realized gains on marketable equity securities of endowment funds amounted to $10,000 in 19X7 and $50,000 
in 19X6.
10. Assets Held in Trust
The Hospital is an income beneficiary of the Thomas A. Smith Trust. Because the assets of the trust are not 
controlled by the Hospital, they are not included in the Hospital's financial statements. At December 31, 19X7, the 
market value of the assets totaled approximately $2,652,000. Distributions of income are made at the discretion of 
the trustees. Income distributed to the Hospital by the trust is restricted for construction or equipment additions 
and amounted to $150,000 in 19X7 and $140,000 in 19X6.
11. Related Party Transactions
Because of the existence of common trustees and other factors, the Hospital and Sample Health Foundation (Foun­
dation) are related parties. The Foundation is authorized by the Hospital to solicit contributions on its behalf. In its 
general appeal for contributions to support the community's providers of health care services, the Foundation also 
solicits contributions for certain other health care institutions. In the absence of donor restrictions, the Foundation 
has discretionary control over the amounts, timing, and use of its distributions.
Contributions made by the Foundation to the Hospital during the years ended December 31, 19X7 and 19X6, are 
reported in the Hospital's financial statements as follows:
19X7 19X6
Unrestricted gifts and bequests
Restricted contributions for—
$375,000 $525,000
Specific purposes 300,000 200,000
Plant replacement and expansion 70,000 85,000
In addition, the Hospital made a capital contribution of $1,000,000 to Sample Health System during 19X6.
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12. Pension Plan
The Hospital has a defined benefit pension plan covering substantially all of its employees. The plan benefits are 
based on years of service and employee compensation during the last five years of covered employment. The Hospital 
makes annual contributions to the plan equal to the amounts of net periodic pension cost. Contributions are 
intended to provide not only for benefits attributed to service to date but also for those expected to be earned in the 
future.
The actuarially computed net periodic pension cost for 19X7 and 19X6 included the following components:
19X7 19X6
Service cost-benefits earned during the
period $ 905,000 $ 770,000
Interest cost on projected benefit obli­
gation 700,000 650,000
Actual return on plan assets (950,000) (800,000)
Net amortization and deferral 70,000 80,000
Net periodic pension cost $ 725,000 $ 700,000
Assumptions used in the accounting for net periodic pension cost were as follows:
As of December 31
19X7 19X6
Discount rates 7.0% 7.0%
Rates of increase in compensation levels 6.0 6.0
Expected long-term rate of return on assets 8.0 8.0
The following table sets forth the plan's funded status and amounts recognized in the Hospital's financial state­
ments at December 31, 19X7 and 19X6.
19X7
Actuarial present value of benefit obligations 
Vested benefit obligation 
Nonvested benefit obligation
Accumulated benefit obligation
Effect of projected future compensation levels
Projected benefit obligation
Plan assets at fair value (primarily listed stocks and U.S. bonds)
Plan assets in excess of projected benefit obligation
Unrecognized net gain from past experience different from that assumed 
Prior service cost not yet recognized in net periodic pension cost 
Unrecognized net asset at January 1, 19X6, being recognized over 15 years 
Prepaid pension cost, included in other assets in the balance sheet
19X6
$6,800,000
1,930,000
8,730,000
980,000
9,710,000
9,800,000
90,000
(40,000)
55,000
(70,000)
$ 35,000
$ 8,020,000 
1,900,000
9,920,000
1,000,000
10,920,000
11,050,000
130,000
(30,000)
50,000
(65,000)
$ 85,000
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13. Commitments
Leases that do not meet the criteria for capitalization are classified as operating leases with related rentals charged 
to operations as incurred.
The following is a schedule by year of future minimum lease payments under operating leases as of December 31, 
19X7, that have initial or remaining lease terms in excess of one year.
Year Ending Minimum Lease
December 31 Payments
19X8 $ 517,000
19X9 506,000
19Y0 459,000
19Y1 375,000
19Y2 343,000
Total minimum lease payments $2,200,000
Total rental expense in 19X7 and 19X6 for all operating leases was approximately $859,000 and $770,000, respectively.
14. Subsequent Event
On February 9, 19X8, the Hospital signed a contract in the amount of $1,050,000 for the purchase of certain real 
estate.
15. Concentrations of Credit Risk
The Hospital is located in Feeling, Illinois. The Hospital grants credit without collateral to its patients, most of whom 
are local residents and are insured under third-party payor agreements. Revenues from patients and third-party 
payors were as follows:
19X7 19X6
Medicare and Medicaid 20% 19%
Blue Cross 20 19
Other third-party payors 
(none over 10%) 27 26
Patients 33 36
100% 100%
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SAMPLE NURSING HOME, INC.
Statements of Income and Retained Earnings
Years Ended December 31, 19X2 and 19X1
Net patient service revenue
Other revenue
Total revenue
Expenses 
Nursing services 
Dietary services 
General services 
Administrative services 
Interest
Provision for bad debts 
Depreciation
Total expenses 
Income from operations
Nonoperating gains—interest and dividends 
Income before provision for income taxes
Provision for income taxes 
Net income
Retained earnings at beginning of year 
Retained earnings at end of year
19X2
$ 2,163,000 
67,000
2,230,000
1,083,000
228,000
212,000
173,000
164,000
92,000
69,000
2,021,000
209,000
18,000
227,000
80,000
147,000
229,000
$ 376,000
19X1
$ 1,949,000 
22,000
1,971,000
1,010,000
225,000
212,000
147,000
172,000
83,000
57,000
1,906,000
65,000
7,000
72,000
29,000
43,000
186,000
$ 229,000
See accompanying notes to financial statements.
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SAMPLE NURSING HOME, INC.
Statements of Cash Flows
Years Ended December 31, 19X2 and 19X1
See accompanying notes to financial statements.
19X2 19X1
Cash flows from operating activities and gains
Cash received from residents and third-party payors $ 2,048,000 $ 1,796,000
Cash received from others 67,000 22,000
Cash paid to employees and suppliers (1,679,000) (1,495,000)
Interest and dividends received 10,000 10,000
Interest paid (160,000) (170,000)
Taxes paid (29,000) (30,000)
Deposits received from patients 35,000 15,000
Deposits refunded to patients (30,000) (20,000)
Net cash provided by operating activities and gains 262,000 128,000
Cash flows from investing activities
Purchase of land held for investment (20,000) —
Purchase of other investments (150,000) —
Proceeds from sale of property — 2,000
Additions to property and equipment (44,000) (79,000)
Cash invested in assets whose use is limited (23,000) —
Increase in notes receivable (9,000) —
Net cash used in investing activities (246,000) (77,000)
Cash flows from financing activities
Repayment of long-term debt (50,000) (50,000)
Net cash used by financing activities (50,000) (50,000)
Net increase (decrease) in cash (34,000) 1,000
Cash at beginning of year 129,000 128,000
Cash at end of year $ 95,000 $ 129,000
Reconciliation of Net Income to Net Cash Provided by Operating Activities and Gains
Net income $147,000 $ 43,000
Adjustments to reconcile net income to net cash provided by 
operating activities and gains
Depreciation 69,000 57,000
Provision for bad debts 92,000 83,000
Amortization 6,000 6,000
Loss on disposal of property — 11,000
Increase (decrease) in deferred income tax liability (8,000) 7,000
Net effect of changes in other receivables, supplies, prepaid expenses,
accounts payable, accrued expenses, and deposits (44,000) (79,000)
Net cash provided by operating activities and gains $262,000 $128,000
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SAMPLE NURSING HOME, INC.
Notes to Financial Statements
December 31, 19X2 and 19X1
1. Summary of Significant Accounting Policies
Sample Nursing Home, Inc. (Company) operates a 128-bed nursing home in Abacus, New State. A summary of the 
Company's significant accounting policies follows.
Income taxes
The provisions for income taxes are based on income reported for financial reporting purposes. Deferred income 
taxes arise from temporary differences between financial and income tax reporting of various items (principally 
depreciation). Tax credits are treated as a reduction of the provision for income taxes in the year in which the credits 
arise.
Patient service revenue
Patient service revenue is reported at the estimated net realizable amounts from residents, third-party payors, and 
others for service rendered.
Revenue under third-party payor agreements is subject to audit and retroactive adjustment. Provisions for esti­
mated third-party payor settlements are provided in the period the related services are rendered. Differences 
between the estimated amounts accrued and interim and final settlements are reported in operations in the year of 
settlement.
Assets whose use is limited
Assets set aside by the board of directors for capital improvements and assets limited as to use under terms of a note 
indenture are classified as assets whose use is limited.
Property and equipment
Property and equipment are recorded at cost. Depreciation is calculated on the straight-line method over the 
estimated useful lives of depreciable assets.
Bond issuance costs
Costs incurred in issuing bonds are being amortized over the term of the bonds using the straight-line method.
Cash and cash equivalents
Cash and cash equivalents include investments in highly liquid debt instruments with a maturity of three months 
or less, excluding amounts whose use is limited by board designation or note indenture.
2. Assets Whose Use Is Limited
Assets whose use is limited under a note indenture agreement at December 31, 19X2 and 19X1, are summarized as 
follows:
19X2 19X1
U.S. Treasury obligations, at cost that approximates market $150,000 $130,000
Cash
Accrued interest income
23,000 21,000
3,000 2,000
$176,000 $153,000
Assets set aside by the board of directors for capital improvements consists of certificates of deposit, at a cost that 
approximates market.
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3. Long-Term Debt
Long-term debt at December 31, 19X2 and 19X1, was as follows:
19X2 19X1
9.5 percent notes payable to the City of Abacus, maturing $50,000 
annually through November 1, 19XX, with a final maturity of $1,000,000 
on November 1, 20XX
Less current maturities
$1,750,000
50,000
$1,700,000
$1,800,000
50,000
$1,750,000
The notes are collateralized by a first-mortgage lien on all property and equipment of the Company and a security 
interest in all of its receipts. The note indenture requires the maintenance of certain deposits with a trustee, which 
are included in assets whose use is limited.
Future maturities of long-term debt as of December 31, 19X2, follow.
19X3 $ 50,000
19X4 50,000
19X5 50,000
19X6 50,000
19X7 50,000
Thereafter 1,500,000
Total $1,750,000
4. Income Taxes
The provisions for income taxes on earnings were as follows:
19X2
Current
Federal $72,000
State 2,000
Total current 74,000
Deferred
Federal 6,000
State —
Total deferred 6,000
Total provision for income taxes $80,000
19X1
$15,000
15,000
13,000
1,000
14,000
$29,000
A reconciliation between the "statutory" federal income tax rate and the effective rate in the statements of income 
is as follows:
19X2 19X1
Statutory tax rate 34% 40%
State taxes, net of federal benefit 1 1
Effective tax rate 35% 41%
5. Pension Plan
[The disclosures contained in this note would be similar to the disclosures contained in note 12 of Sample Hospital 
and therefore are not repeated here.]
6. Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in note 15 of Sample Hospital 
and therefore are not repeated here.]
83
SA
M
PL
E 
CO
NT
IN
UI
NG
 C
AR
E 
RE
TI
RE
M
EN
T 
CO
M
M
UN
IT
Y
Ba
la
nc
e S
he
et
s
De
ce
m
be
r 3
1,
 19
X5
 an
d 1
9X
4
Li
ab
ili
tie
s a
nd
 Fu
nd
 D
ef
ic
it 
19
X5
 
19
X4
Cu
rr
en
t l
ia
bi
lit
ie
s
Cu
rr
en
t m
at
ur
iti
es
 of
 lo
ng
-te
rm
 d
eb
t $ 90,000 
$ 
77
,0
00
A
cc
ou
nt
s p
ay
ab
le
 
18
0,
00
0 
17
4,
00
0
A
cc
ru
ed
 ex
pe
ns
es
 
16
1,
00
0 
17
8,
00
0
D
ep
os
its
 on
 u
no
cc
up
ie
d 
un
its
 
22
,0
00
 
40
,0
00
To
ta
l c
ur
re
nt
 li
ab
ili
tie
s 
45
3,
00
0 
46
9,
00
0
Lo
ng
-te
rm
 d
eb
t, l
es
s c
ur
re
nt
 m
at
ur
iti
es
 
8,
87
1,
00
0 
8,
93
5,
00
0
Re
fu
nd
ab
le
 fe
es
 
59
,0
00
 
14
4,
00
0
Es
tim
at
ed
 ob
lig
at
io
n 
to
 pr
ov
id
e f
ut
ur
e 
se
rv
ic
es
, in
 ex
ce
ss
 of
 am
ou
nt
s
re
ce
iv
ed
 or
 to
 b
e r
ec
ei
ve
d 
88
,0
00
 
10
0,
00
0
D
ef
er
re
d 
re
ve
nu
e f
ro
m
 ad
va
nc
e f
ee
s 
9,
30
4,
00
0 
9,
58
5,
00
0
Fu
nd
 d
ef
ic
it 
(9
52
,0
00
) 
(1
,4
89
,0
00
)
To
ta
l li
ab
ili
tie
s a
nd
 fu
nd
 de
fic
it 
$1
7,
82
3,
00
0 
$1
7,
74
4,
00
0
__
__
__
__
__
__
__
_A
ss
et
s_
__
__
__
__
__
__
__
 19X5 1
9X
4
Cu
rr
en
t a
ss
et
s
Ca
sh
 
$ 
37
5,
00
0 
$ 
33
0,
00
0
A
cc
ou
nt
s r
ec
ei
va
bl
e (
ne
t o
f
al
lo
w
an
ce
fo
r d
ou
bt
fu
l a
cc
ou
nt
s o
f $
4,
00
0
an
d 
$5
,0
00
) 
18
7,
00
0 
19
7,
00
0
Su
pp
lie
s 
40
,0
00
 
21
,0
00
Pr
ep
ai
d 
ex
pe
ns
es
 
15
,0
00
 
 8,000
To
ta
l c
ur
re
nt
 as
se
ts
 
61
7,
00
0 
55
6,
00
0
A
ss
et
s w
ho
se
 us
e i
s l
im
ite
d
U
nd
er
 n
ot
e a
gr
ee
m
en
t—
in
ve
st
m
en
ts
 
2,
13
0,
00
0 
1,
75
3,
00
0
By
 b
oa
rd
 fo
r c
ap
ita
l im
pr
ov
em
en
ts
—
in
ve
st
m
en
ts
 
10
0,
00
0 
65
,0
00
2,
23
0,
00
0 
1,
81
8,
00
0
Pr
op
er
ty
 an
d 
eq
ui
pm
en
t
La
nd
 
55
7,
00
0 
55
7,
00
0
La
nd
 im
pr
ov
em
en
ts 
20
5,
00
0 
20
3,
00
0
Bu
ild
in
gs
 an
d 
im
pr
ov
em
en
ts
 
14
,5
73
,0
00
 
14
,5
64
,0
00
Fu
rn
itu
re
 an
d 
eq
ui
pm
en
t 
75
2,
00
0 
69
8,
00
0
16
,0
87
,0
00
 
16
,0
22
,0
00
A
cc
um
ul
at
ed
 de
pr
ec
ia
tio
n 
1,
19
4,
00
0 
74
2,
00
0
N
et
 p
ro
pe
rty
 an
d 
eq
ui
pm
en
t 
14
,8
93
,0
00
 
15
,2
80
,0
00
D
ef
er
re
d 
fin
an
cin
g c
os
ts
 (n
et
 of
 
ac
cu
m
ul
at
ed
 am
or
tiz
at
io
n o
f $
28
,0
00
an
d 
$2
1,
00
0)
 
83
,0
00
 
90
,0
00
To
ta
l a
ss
et
s 
$1
7,
82
3,
00
0 
$1
7,
74
4,
00
0
Se
e a
cc
om
pa
ny
in
g n
ot
es
 to
 fi
na
nc
ia
l s
ta
te
m
en
ts
.
84
SAMPLE CONTINUING CARE RETIREMENT COMMUNITY
Statements of Revenue and Expenses and Changes in Fund Deficit
Years Ended December 31, 19X5 and 19X4
19X5 19X4
Revenue
Resident services, including amortization of advance fees of 
$935,000 and $915,000
Patient revenue from nonresidents
Investment income
Other
Total revenue
Expenses 
Resident care 
Dietary 
Housekeeping 
Plant
General and administrative
Depreciation
Interest
Total expenses
Decrease (increase) in obligation to provide future services and use of 
facilities to current residents
Income (loss) from operations 
Nonoperating gains—Contributions
Revenue and gains in excess of (less than) expenses 
Fund deficit, beginning of year 
Fund deficit, end of year
$ 3,946,000 
249,000 
107,000 
75,000
4,377,000
649,000
781,000
185,000
491,000
436,000
452,000
967,000
3,961,000
416,000
12,000
428,000
109,000
537,000
(1,489,000)
$ (952,000)
$ 3,152,000 
275,000 
78,000 
68,000
3,573,000
566,000
701,000
170,000
421,000
445,000
447,000
955,000
3,705,000
(132,000)
(82,000)
(214,000)
73,000
(141,000)
(1,348,000)
$(1,489,000)
See accompanying notes to financial statements.
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SAMPLE CONTINUING CARE RETIREMENT COMMUNITY
Statements of Cash Flows
Years Ended December 31, 19X5 and 19X4
See accompanying notes to financial statements.
19X5 19X4
Cash flows from operating activities and nonoperating gains
Cash received from residents and third-party payors $ 3,252,000 $ 2,341,000
Other receipts from operations 75,000 68,000
Investment income received 109,000 73,000
Contributions received 107,000 78,000
Cash paid to employees and suppliers (2,589,000) (2,042,000)
Interest paid (950,000) (945,000)
Net cash provided (used) by operating activities and nonoperating gains 4,000 (427,000)
Cash flows from investing activities
Acquisition of property and equipment (65,000) (250,000)
Cash invested in assets whose use is limited (412,000) (238,000)
Assets whose use is limited used for acquisition of property and equipment — 467,000
Net cash used by investing activities (477,000) (21,000)
Cash flows from financing activities
Proceeds from advance fees and deposits 615,000 857,000
Refunds of advance fees and deposits (46,000) (52,000)
Proceeds from issuance of long-term debt 26,000 —
Repayments of long-term debt (77,000) (307,000)
Net cash provided by financing activities 518,000 498,000
Net increase in cash 45,000 50,000
Cash at beginning of year 330,000 280,000
Cash at end of year $ 375,000 $ 330,000
Reconciliation of Revenue and Gains in Excess of (Less Than) Expenses 
to Net Cash Provided (Used) by Operating Activities and Nonoperating Gains
Revenue and gains in excess of (less than) expenses $ 537,000 $ (141,000)
Adjustments to reconcile revenue and gains in excess of (less than) expenses 
to net cash provided (used) by operating activities and nonoperating gains
Amortization of advance fees (935,000) (915,000)
Loss (gain) on obligation to provide future services (12,000) 82,000
Depreciation and amortization 459,000 475,000
Provision for bad debts 3,000 3,000
Net change in receivables, supplies, and payables (48,000) 69,000
Net cash provided (used) by operating activities and
nonoperating gains $ 4,000 $ (427,000)
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SAMPLE CONTINUING CARE RETIREMENT COMMUNITY
Notes to Financial Statements
December 31, 19X5 and 19X4
1. Summary of Significant Accounting Policies
Sample Continuing Care Retirement Community (CCRC) provides housing, health care, and other related services 
to residents through the operation of a retirement facility containing 249 apartments and a seventy-eight-bed health 
care facility. A summary of significant accounting policies follows.
Advance fees
Fees paid by a resident upon entering into a continuing care contract, net of the portion thereof that is refundable 
to the resident, are recorded as deferred revenue and are amortized to income using the straight-line method over 
the estimated remaining life expectancy of the resident.
Obligation to provide future services
CCRC annually calculates the present value of the net cost of future services and use of facilities to be provided to 
current residents and compares that amount with the balance of deferred revenue from advance fees. If the present 
value of the net cost of future services and use of facilities exceeds the deferred revenue from advance fees, a liability 
is recorded (obligation to provide future services and use of facilities) with the corresponding charge to income. The 
obligation is discounted at 9 percent, based on the expected long-term rate of return on government obligations. 
Investments
Investments, which consist of U.S. Treasury obligations, are stated at cost, which approximates fair market value. 
Interest and investment income are recognized when earned.
2. Property and Equipment
Property and equipment are stated at cost. Donated property is recorded at its estimated fair value at date of receipt, 
which then is treated as cost. Depreciation is computed on the straight-line method based on the following 
estimated useful lives:
Land improvements 20 years
Buildings and improvements 40 years
Furniture and equipment 5-15 years
When assets are retired or otherwise disposed of, the cost and related accumulated depreciation are removed from 
the accounts, and any resulting gain or loss is recognized in income for the period. The cost of maintenance and 
repairs is expensed as incurred; significant renewals and betterments are capitalized.
3. Deferred Financing Costs
Deferred financing costs are being amortized using the interest method over the term of the related financing 
agreement.
4. Tax Status
CCRC is a not-for-profit corporation as described in Section 501(c)(3) of the Internal Revenue Code and is exempt 
from federal income taxes pursuant to Section 501(a) of the Internal Revenue Code.
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5. Long-Term Debt
Long-term debt at December 31, 19X5 and 19X4, is as follows:
19X5 19X4
10.75% mortgage note payable $8,901,000 $8,965,000
Notes payable to bank—unsecured 34,000 14,000
Other 26,000 33,000
8,961,000 9,012,000
Less current maturities 90,000 77,000
$8,871,000 $8,935,000
The mortgage note is payable in consecutive monthly installments of principal and interest of $85,425 to May 20XX. 
The note is collateralized by a first mortgage on property and equipment with a depreciated value at December 31, 
19X5, of $14,893,000 and by a pledge of all operating revenue.
As required by the mortgage note agreement, CCRC established an initial debt service reserve fund of $1,000,000 
at April 15, 19X3. All resident fees received thereafter, net of resident fee refunds and debt service payments not to 
exceed $300,000 annually in the first four years and $200,000 annually thereafter, are to be added to the debt service 
reserve fund until the total sum of $2,050,000 is accumulated. Since June 1, 19X4, CCRC is required to deliver to the 
Trustee $5,500 per month to establish maintenance reserves until the aggregate of such payments equals a residen­
tial unit reserve and a health care center reserve of $240,000 and $90,000, respectively. At December 31, 19X5, the 
trustee held investments aggregating $2,130,000. Such amount has been classified as assets whose use is limited. 
Scheduled annual principal maturities of long-term debt for the next five years are as follows:
19X6 $ 90,000
19X7 90,000
19X8 95,000
19X9 105,000
19Y0 105,000
6. Assets Whose Use Is Limited
[The disclosures contained in this note would be similar to the disclosures contained in Note 5 of Sample Hospital 
and therefore are not repeated here.]
7. Pension Plan
[The disclosures contained in this note would be similar to the disclosures contained in Note 12 of Sample Hospital 
and therefore are not repeated here.]
8. Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in Note 15 of Sample Hospital 
and therefore are not repeated here.]
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SAMPLE HOME HEALTH AGENCY
Statements of Revenue and Expenses and Changes in Fund Balance
Years Ended December 31, 19X5 and 19X4
19X5 19X4
Net patient service revenue (note 2) $ 4,042,000 $ 2,687,000
Other revenue 27,000 32,000
Total revenue 4,069,000 2,719,000
Expenses (note 5)
Professional care of patients 2,714,000 1,835,000
General and administrative 1,042,000 675,000
Occupancy 90,000 83,000
Provision for bad debts 46,000 21,000
Depreciation 21,000 15,000
Interest  16,000  19,000
Total expenses 3,929,000 2,648,000
Income from operations 140,000 71,000
Nonoperating gains
Contributions 19,000 15,000
Investment income 18,000 12,000
Total nonoperating gains 37,000 27,000
Revenue and gains in excess of expenses 177,000 98,000
Fund balance at beginning of year 252,000 154,000
Fund balance at end of year $ 429,000 $ 252,000
See accompanying notes to financial statements.
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SAMPLE HOME HEALTH AGENCY
Statements of Cash Flows
Years Ended December 31, 19X5 and 19X4
See accompanying notes to financial statements.
19X5 19X4
Cash flows from operating activities and nonoperating gains
Cash received from customers and third-party payors $ 3,721,000 $ 2,542,000
Other receipts from operations 22,000 32,000
Cash paid to employees and suppliers (3,683,000) (2,540,000)
Interest paid (11,000) (14,000)
Nonoperating gains 37,000 27,000
Net cash provided by operating activities and nonoperating gains 86,000 47,000
Cash flows from investing activities
Purchase of equipment (30,000) (19,000)
Purchase of investments (10,000) (15,000)
Net cash used by investing activities (40,000) (34,000)
Cash flows from financing activities
Payment of long-term debt (13,000)
Net cash used by financing activities (13,000)
Net increase in cash and cash equivalents 33,000 13,000
Cash and cash equivalents at beginning of year 41,000 28,000
Cash and cash equivalents at end of year $ 74,000 $ 41,000
Reconciliation of Revenue and Gains in Excess of Expenses to Net Cash Provided 
by Operating Activities and Nonoperating Gains
Revenue and gains in excess of expenses $ 177,000 $ 98,000
Adjustments to reconcile revenue and gains in excess of expenses 
to net cash provided by operating activities and nonoperating gains
Provision for bad debts 46,000 21,000
Depreciation and amortization 26,000 20,000
Increase in accounts receivable (322,000) (150,000)
Increase in other receivables (5,000) (2,000)
Increase in accounts payable and accrued expenses 163,000 50,000
Decrease (increase) in estimated third-party receivables (3,000) 3,000
Increase in advances from third-party payors 4,000 7,000
Net cash provided by operating activities and nonoperating gains $ 86,000 $ 47,000
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SAMPLE HOME HEALTH AGENCY
Notes to Financial Statements
Years Ended December 31,19X5 and 19X4
1. Summary of Significant Accounting Policies
Sample Home Health Agency (the Agency) was incorporated in 19X0 as a not-for-profit corporation. The Agency 
provides health and supportive services to individuals at their homes.
Charity care
The Agency has a policy of providing charity care to patients who are unable to pay. Such patients are identified 
based on financial information obtained from the patient and subsequent analysis. Since the Agency does not expect 
payment, estimated charges for charity care are not included in revenue.
Net, patient service revenue
Net patient service revenue represents the estimated net realizable amounts from patients, third-party payors, and 
others for services rendered.
Income taxes
The Agency is a not-for-profit corporation as described in Section 501(c)(3) of the Internal Revenue Code and is 
exempt from federal income taxes on related income pursuant to Section 501(a) of the Code.
Assets whose use is limited
Assets set aside for board-designated purposes are classified as assets whose Use is limited.
Investments
Investments consist of U.S. Treasury obligations at cost, which approximates market value.
Equipment
Equipment is recorded at cost. Depreciation is computed using the straight-line method over the estimated useful 
lives of the assets.
Cash and cash equivalents
Cash and cash equivalents include investments in highly liquid debt instruments with a maturity of three months 
or less, excluding amounts whose use is limited by board designation.
2. Third-Party Rate Adjustments and Revenue
Approximately 38 percent in 19X5 and 37 percent in 19X4 of net patient service revenue was derived under federal 
and state third-party reimbursement programs. These revenues are based, in part, on cost reimbursement prin­
ciples and are subject to audit and retroactive adjustment by the respective third-party fiscal intermediaries. In the 
opinion of management, retroactive adjustments, if any, would not be material to the financial position, results of 
operations or cash flows of the Agency.
3. Board-Designated Assets
The board of directors has designated cash and investments aggregating $135,000 to be used for future major capital 
improvements. Those assets are classified in the balance sheets as assets whose use is limited.
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4. Long-Term Debt
Long-term debt at December 31, 19X5 and 19X4, is as follows:
19X5 19X4
Note payable to bank, interest at 15%, collateralized by equipment 
with a depreciated cost in 19X5 of $42,000
Less current maturities
Long-term debt, less current maturities
Scheduled maturities of long-term debt at December 31, 19X5 are as follows
$118,000 $131,000
13,000 13,000
$105,000 $118,000
19X6 $ 13,000
19X7 13,000
19X8 13,000
19X9 13,000
19X0 13,000
Thereafter 53,000
Total $118,000
5. Pension Plan
[The disclosures contained in this note would be similar to the disclosures contained in note 12 of Sample 
Hospital.]
6. Charity Care
Charity care represented approximately 3 percent and 4 percent of visits in 19X5 and 19X4, respectively.
7. Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in note 15 of Sample 
Hospital.]
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SAMPLE HEALTH MAINTENANCE ORGANIZATION
Statements of Revenue and Expenses 
and Changes in Fund Balance 
Years Ended June 30, 19X5 and 19X4
19X5
Revenue
Premiums earned $27,682,000
Coinsurance 689,000
Interest and other income 242,000
28,613,000
Expenses
Contracted hospital, physician, and other services 12,749,000
Health centers—medical services 10,116,000
Health centers—administration 1,556,000
General administration 1,695,000
Membership services 527,000
Interest 385,000
Depreciation and amortization 367,000
27,395,000
Income from operations 1,218,000
Fund balance at beginning of year 900,000
Fund balance at end of year $ 2,118,000
19X4
$22,500,000
500,000
100,000
23,100,000
9,734,000
8,786,000
1,530,000
1,309,000
440,000
375,000
336,000
22,510,000
590,000
310,000
$ 900,000
See accompanying notes to financial statements.
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SAMPLE HEALTH MAINTENANCE ORGANIZATION
Statements of Cash Flows
Years Ended June 30, 19X5 and 19X4
19X5 19X4
Cash flows from operating activities 
Cash received from premiums, stop-loss insurance recoveries,
and coinsurance $ 28,969,000 $ 24,410,000
Cash paid to employees and to providers of health care services (26,405,000) (22,818,000)
Interest received 230,000 90,000
Interest paid (382,000) (372,000)
Net cash provided by operating activities 2,412,000 1,310,000
Cash flows from investing activities
Additions to property and equipment (497,000) (121,000)
Net cash used by investing activities (497,000) (121,000)
Cash flows from financing activities
Proceeds from long-term debt 300,000 —
Repayment of long-term debt (299,000) (1,000,000)
Net cash provided (used) by financing activities 1,000 (1,000,000)
Net increase in cash and temporary cash investments 1,916,000 189,000
Beginning cash and temporary cash investments 1,021,000 832,000
Ending cash and temporary cash investments $ 2,937,000 $ 1,021,000
Reconciliation of Income From Operations to Net Cash Provided
by Operating Activities
Income from operations $ 1,218,000 $ 590,000
Adjustments to reconcile income from operations to net cash provided
by operating activities
Depreciation and amortization 370,000 339,000
Increase in accounts payable—medical services 774,000 335,000
Increase (decrease) in unearned premium revenue (61,000) 115,000
Decrease in premiums receivable 49,000 84,000
Net effect of changes in other receivables, supplies, prepaid expenses,
and other payables 62,000 (153,000)
Net cash provided by operating activities $ 2,412,000 $ 1,310,000
See accompanying notes to financial statements.
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SAMPLE HEALTH MAINTENANCE ORGANIZATION
Notes to Financial Statements
June 30, 19X5 and 19X4
1. Formation and Purpose
Sample Health Maintenance Organization (Sample HMO) was incorporated in 19X0 as a not-for-profit corporation 
for the purpose of providing comprehensive health care services on a prepaid basis and for the purpose of establish­
ing and operating organized health maintenance and health care delivery systems.
Sample HMO has been determined to be a qualified health maintenance organization (HMO) under Title XIII of the 
Public Health Service Act.
2. Summary of Significant Accounting Policies
Temporary cash investments
Temporary cash investments at June 30, 19X5 and 19X4, include a repurchase agreement with a bank and certificates 
of deposit with original maturities of less than ninety days carried at a cost that is equivalent to market.
Premiums revenue
Membership contracts are on a yearly basis subject to cancellation by the employer group or Sample HMO upon 
thirty days written notice. Premiums are due monthly and are recognized as revenue during the period in which 
Sample HMO is obligated to provide services to members.
Health care service cost recognition
Sample HMO contracts with various health care providers for the provision of certain medical care services to its 
members. Sample HMO compensates those providers on a capitation basis. As part of a cost control incentive 
program, Sample HMO retains up to XX percent of the capitation as a risk-sharing fund. In the event of hospital 
utilization in excess of budget, those providers bear the risk to the extent of XX percent of the capitation fee. 
Operating expenses include all amounts incurred by Sample HMO under the aforementioned contracts.
The cost of other health care services provided or contracted for is accrued in the period in which it is provided 
to a member based in part on estimates, including an accrual for medical services provided but not reported to 
Sample HMO.
Inventories of supplies
Inventories of drugs and other supplies are stated at the lower of cost (first-in, first-out) or market.
Property and equipment
Property and equipment are recorded at cost, less accumulated depreciation. Maintenance and repairs are charged 
to expense, and betterments are capitalized. Property and equipment costing approximately $700,000 was financed 
by initial development grants received in 19X1 and 19X2 from the U.S. Department of Health and Human Services. 
This property will be owned by Sample HMO as long as the equipment and facilities are used for projects related 
to the objectives of the Public Health Service Act.
Depreciation is computed using the straight-line method over the estimated useful lives of the related assets as 
follows:
Building 40 years
Improvements 20-25 years
Data processing and laboratory equipment and automobiles 3-7 years
Medical equipment 10 years
Office equipment 5-10 years
Amortization of debt issuance costs
Debt issuance costs are deferred and amortized using the interest method over the term of the related debt.
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Retirement plan expense
Sample HMO has a retirement plan as more fully described in note 6. Charges to expense are recognized when 
Sample HMO makes contributions to the plan.
Federal income tax
Sample HMO is exempt from federal income taxes under Section 501(c)(4) of the Internal Revenue Code; accord­
ingly, no provision for federal income taxes has been made in the accompanying financial statements.
Reinsurance (stop-loss insurance)
Reinsurance premiums are reported as health care costs, and reinsurance recoveries are reported as revenue.
3. Property and Equipment
Property and equipment at June 30, 19X5 and 19X4, consists of the following:
19X419X5
Land $ 300,000 $ 300,000
Buildings and improvements 5,473,000 5,459,000
Furniture and equipment 1,786,000
7,559,000
1,303,000
7,062,000
Less accumulated depreciation 1,803,000
$ 5,756,000
1,436,000
$ 5,626,000
4. Long-Term Debt
Long-term debt is collateralized by assets with a depreciated cost at June 30, 19X5 of $4,943,000. A summary of long­
term debt at June 30, 19X5 and 19X4, follows.
19X5 19X4
HHS loan, interest at 7.5%
HHS loan, interest at 9.25%
Secured equipment loans
$ 2,020,000 
1,658,000 
858,000
$ 2,111,000 
1,694,000 
686,000
4,536,000 4,491,000
Less portion payable within one year 241,000 109,000
$ 4,295,000 $ 4,382,000
Scheduled principal payments on long-term debt are as follows:
Scheduled Principal
Fiscal Year Payments
19X6 $ 241,000
19X7 259,000
19X8 280,000
19X9 800,000
19Y0 2,956,000
$4,536,000
5. State Guarantee Fund Deposit
In August 19X5 the state in which Sample HMO is domiciled enacted legislation specifically governing HMOs. 
Under this legislation, Sample HMO is required to maintain a deposit of $150,000 with the director of the division 
of insurance of the state.
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6. Employee Retirement Plan
Sample HMO has a contributory defined contribution retirement plan covering substantially all employees. 
Expense determined in accordance with the plan formula (4 percent to 10 percent of eligible covered compensation) 
was $354,000 for the year ended June 30, 19X5 ($275,000 for 19X4).
7. Stop-loss Insurance
Sample HMO has entered into a stop-loss insurance agreement with an insurance company to limit its losses 
on individual claims. Under the terms of this agreement, the insurance company will reimburse Sample HMO 
approximately XX percent of the cost of each member's annual hospital services, in excess of a $XXX deductible, 
up to a lifetime limitation of $XXX per member. In the event Sample HMO ceases operations, (a) plan benefits will 
continue for members who are confined in an acute care hospital on the date of insolvency until their discharge and 
(b) plan benefits will continue for any other member until the end of the contract period for which premiums have 
been paid.
Stop-loss insurance premiums of approximately $700,000 and $500,000 are included in health care costs in 19X5 and 
19X4, respectively. Approximately $600,000 and $400,000 of stop-loss insurance recoveries are deducted from health 
care costs in 19X5 and 19X4, respectively.
Included in other receivables is approximately $50,000 recoverable from insurers.
8. Malpractice Claims
Malpractice claims have been asserted against Sample HMO by various claimants. The claims are in various stages 
of processing, and some may ultimately be brought to trial. In the opinion of counsel, the outcome of these actions 
will not have a significant effect on the financial position, results of operations or cash flows of Sample HMO. 
Incidents occurring through June 30, 19X5, may result in the assertion of additional claims. Other claims may be 
asserted arising from past services provided. Management believes that these claims, if asserted, would be settled 
within the limits of insurance coverage.
9. Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in note 15 of Sample Hospital.]
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SAMPLE AMBULATORY CARE, INC.
Statements of Revenue and Expenses 
and Changes in Fund Balance 
Years Ended December 31, 19X5 and 19X4
Net patient service revenue (note 7)
Operating gains
Total operating revenue and gains 
Expenses
Salaries and wages 
Employee benefits 
Supplies
Purchased services 
Insurance 
Professional fees 
Interest 
Depreciation
Total expenses 
Loss from operations
Nonoperating gain—interest income
Expenses in excess of revenue and gains
Fund balance at beginning of period 
Fund balance at end of period
19X5
$ 860,000 
26,000
886,000
425,000
77,000
107,000
177,000
34,000
27,000
15,000
117,000
979,000
(93,000)
3,000
(90,000)
2,541,000
$2,451,000
19X4
$ 357,000 
14,000
371,000
184,000
54,000
52,000
109,000
22,000
1,000
17,000
100,000
539,000
(168,000)
11,000
(157,000)
2,698,000
$2,541,000
See accompanying notes to financial statements.
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SAMPLE AMBULATORY CARE, INC.
Statements of Cash Flows
Years Ended December 31, 19X5 and 19X4
19X5 19X4
Cash flows from operating activities and gains
Cash received from patients and third-party payors $ 866,000
Cash received from others 21,000
Interest received 3,000
Interest paid (15,000)
Cash paid to employees and suppliers (870,000)
Net cash provided from (used for) operating activities and gains 5,000
Cash flows from investing activities
Purchase of equipment (1,000)
Advances made (9,000)
Net cash used for investing activities (10,000)
Cash flows from financing activities
Proceeds from notes payable —
Payments on notes payable (6,000)
Net cash provided from (used for) financing activities (6,000)
Net increase (decrease) in cash (11,000)
Cash at beginning of year 76,000
Cash at end of year $ 65,000
$ 368,000 
6,000
11,000
(16,000)
(432,000)
(63,000)
(4,000)
(5,000)
(9,000)
144,000
144,000
72,000
4,000
$ 76,000
Reconciliation of Net Loss to Net Cash Provided From (Used For)
Operating Activities and Gains
Net loss $ (90,000)
Adjustments to reconcile net loss to net cash provided from (used for) operating 
activities and gains
Depreciation 117,000
Provision for bad debts 14,000
Net increase in receivables and net third-party payor adjustments (12,000)
Net decrease (increase) in inventories of supplies, prepaid expenses and deposits 1,000
Net increase (decrease) in accounts payable, accrued expenses and advances
from Blue Cross (25,000)
Net cash provided from (used for) operating activities and gains $ 5,000
$(157,000)
100,000
4,000
(19,000)
(2,000)
11,000
$ (63,000)
See accompanying notes to financial statements.
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SAMPLE AMBULATORY CARE, INC.
Notes to Financial Statements
December 31, 19X5 and 19X4
1. Summary of Significant Accounting Policies
Net patient service revenue
Patient service revenue is reported at the estimated net realizable amounts from patients, third-party payors, and 
others for services rendered.
Third-party contractual adjustments
Retroactively calculated third-party contractual adjustments are accrued on an estimated basis in the period the 
related services are rendered. Net patient service revenue is adjusted as required in subsequent periods based on 
final settlements.
Charity care
Sample Ambulatory Care, Inc. has a policy of providing charity care to patients who are unable to pay. Such patients 
are identified and related charges are estimated, based on financial information obtained from the patient and 
subsequent analysis. Since management does not expect payment for charity care, the estimated charges are 
excluded from revenue.
Supplies
Supplies are stated at the lower of cost (first-in, first-out) or net realizable value.
Depreciation
Depreciation of property and equipment is computed on the straight-line method over the estimated lives of 
depreciable assets.
Investment income
Investment income and gains on investment transactions are recorded as nonoperating revenue.
2. Formation and Scope of Operations
Sample Ambulatory Care, Inc. was incorporated on September 7, 19X3, to operate an ambulatory care health facility 
to treat or prevent injury and disease, to provide funds or to expend funds to further the treatment or prevention 
of injury or disease, and to develop and participate in activities designed to promote the general health of the 
community.
Three area hospitals—ABC Hospital and Health Center, DEF Hospital, and GHI Hospital—entered into a members' 
agreement to develop this ambulatory care center. In accordance with this agreement, each hospital contributed 
capital of $947,000 to Sample Ambulatory Care, Inc.
Sample Ambulatory Care, Inc. began operations in October 19X3.
3. Related Party Transactions
During 19X3, Sample Ambulatory Care, Inc. entered into a contract with one of the member hospitals (managing 
hospital) for the management of the business and affairs of Sample Ambulatory Care, Inc. Under this agreement, 
Sample Ambulatory Care, Inc. pays $4,000 per month to the managing hospital. The agreement with the managing 
hospital was to remain in effect through December 31, 19X5, but has been extended on a month-to-month basis.
In addition, during 19X4, each hospital loaned $48,000 to Sample Ambulatory Care, Inc. in the form of promissory 
notes at an interest rate of prime plus one percent (effective rates of 10 percent and 9 percent in 19X5 and 19X4, 
respectively). Of the total $144,000 liability, $48,000 is payable on demand after November 28, 19X5, to one member 
hospital, with the remaining portion ($96,000) payable on demand after December 8, 19X5, to the other two member 
hospitals. During 19X5, Sample Ambulatory Care, Inc. paid $2,000 to each member hospital, thereby reducing the 
obligation to $138,000.
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4. Revenue From Contracting Agencies
Sample Ambulatory Care, Inc. participates as a provider of health care services to Blue Cross, Medicare, and 
County Indigent Plan patients. Reimbursement for covered services is based on tentative payment rates. Final 
reimbursement rates are determined after submission of annual cost reports and audits thereof by the fiscal inter­
mediaries. Provisions for estimated reimbursement adjustments are reported in the financial statements in the 
period that the services are rendered.
5. Advances Receivable
In May 19X4 Sample Ambulatory Care, Inc. entered into a five-year agreement with XYZ Affiliates (XYZ). Under 
this agreement, XYZ is to provide emergency medical services as well as charge and bill each patient treated at 
Sample Ambulatory Care, Inc. Sample Ambulatory Care, Inc. has guaranteed that XYZ will collect at least $18,000 
per month during the term of this agreement. In any month in which XYZ does not collect the minimum guarantee, 
Sample Ambulatory Care, Inc. advances funds to XYZ to cover the deficiency. Such advances are to be repaid to the 
extent XYZ's net cash collections exceed the minimum guarantee amount. Management estimates that the advances 
will be fully recovered in 19X6.
6. Income Taxes
Sample Ambulatory Care, Inc. is a not-for-profit corporation as described in Section 501(c)(3) of the Internal 
Revenue Code and is exempt from federal income taxes on related income pursuant to Section 501(a) of the Code.
7. Charity Care
Sample Ambulatory Care, Inc. has a policy of providing charity care to indigent patients in emergency situations. 
These services, which are excluded from revenues, amounted to $27,000 and $13,000 in 19X3 and 19X4, respectively, 
when measured at Sample Ambulatory Care, Inc.'s established rates.
8. Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in note 15 of Sample Hospital.]
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[Date]
UNQUALIFIED OPINION—COMPARATIVE 
FINANCIAL STATEMENTS
Independent Auditor's Report
To the Board of Trustees
XYZ Health Care Entity
We have audited the accompanying balance sheets of XYZ Health Care Entity as of September 30, 19X2 and 19X1, 
and the related statements of revenue and expenses of general funds, changes in fund balances, and cash flows of 
general funds for the years then ended. These financial statements are the responsibility of XYZ Health Care 
Entity's management. Our responsibility is to express an opinion on these financial statements based on our audits.
We conducted our audits in accordance with generally accepted auditing standards. Those standards require that 
we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of 
material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and 
disclosures in the financial statements. An audit also includes assessing the accounting principles used and signifi­
cant estimates made by management, as well as evaluating the overall financial statement presentation. We believe 
that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the financial posi­
tion of XYZ Health Care Entity as of September 30, 19X2 and 19X1, and the results of its operations and its cash flows 
of general funds for the years then ended in conformity with generally accepted accounting principles.
[Signature]
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[Date]
UNQUALIFIED OPINION WITH EXPLANATORY PARAGRAPH — 
MATERIAL UNCERTAINTY
Independent Auditor's Report
To the Board of Trustees 
XYZ Health Care Entity
[Standard wording for first three paragraphs]
As more fully described in note X, claims in excess of professional liability insurance coverage have been asserted 
against XYZ Health Care Entity. Legal counsel and management are unable to estimate the ultimate cost, if any, that 
may result from the resolution of those claims; accordingly, no provision for claims in excess of professional liability 
insurance has been made in the accompanying financial statements.
[Signature]
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QUALIFIED OPINION—SCOPE LIMITATION
Independent Auditor's Report
[Date]
To the Board of Trustees 
XYZ Health Care Entity
[Same first paragraph as the standard report]
Except as discussed in the following paragraph, we conducted our audits in accordance with generally accepted 
auditing standards. Those standards require that we plan and perform the audit to obtain reasonable assurance 
about whether the financial statements are free of material misstatement. An audit includes examining, on a test 
basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes 
assessing the accounting principles used and significant estimates made by management, as well as evaluating the 
overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
We were unable to obtain audited financial statements supporting XYZ Health Care Entity's investment in an
affiliate stated at $____________ and $_____________at September 30, 19X2 and 19X1, respectively, or its equity in the
earnings of that affiliate of $____________ and $_____________ , which amounts are included in the excess of
revenues and gains over expenses for the years then ended as described in Note X to the financial statements; nor 
were we able to satisfy ourselves as to the carrying value of the investment in the affiliate or the equity in its earnings 
by other auditing procedures.
In our opinion, except for the effects of such adjustments, if any, as might have been determined to be necessary 
had we been able to obtain adequate evidence regarding the affiliate investment and earnings, the financial statements 
referred to in the first paragraph present fairly, in all material respects, the financial position of XYZ Health Care 
Entity as of September 30, 19X2 and 19X1, and the results of its operations and its cash flows of general funds for 
the years then ended in conformity with generally accepted accounting principles.
[Signature]
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[Date]
QUALIFIED OPINION—DEPARTURE FROM GENERALLY 
ACCEPTED ACCOUNTING PRINCIPLES
Independent Auditor's Report
To the Board of Trustees
XYZ Health Care Entity
[Same first and second paragraphs as the standard report]
XYZ Health Care Entity has excluded, from property and debt in the accompanying balance sheets, certain lease 
obligations that, in our opinion, should be capitalized to conform with generally accepted accounting principles.
If these lease obligations were capitalized, property would be increased by $____________ and $_____________ ,
long-term debt would be increased by $____________ and $_____________ , and the general fund balance would be
increased by $____________ and $_____________as of September 30, 19X2 and 19X1, respectively. In addition, the
excess of revenue over expenses would be increased by $____________ and $_____________ , respectively, for the
years then ended.
In our opinion, except for the effects of not capitalizing certain lease obligations as discussed in the preceding 
paragraph, the financial statements referred to in the first paragraph present fairly, in all material respects, the 
financial position of XYZ Health Care Entity as of September 30, 19X2 and 19X1, and the results of its operations 
and its cash flows of general funds for the years then ended in conformity with generally accepted accounting 
principles.
[Signature]
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TECHNICAL HOTLINE
The AICPA Technical Information Service answers 
inquiries about specific audit or accounting problems. 
Call Toll Free
(800) 223-4158 (Except New York)
(800) 522-5430 (New York Only)
This service is free to AICPA members.
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